(+)-(S)-ar-turmerone affects binding ISO RGD:69168 6480464 ar-turmerone binds to PPARG protein CTD PMID:15713005 (+)-catechin multiple interactions ISO RGD:3371 6480464 Catechin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA] CTD PMID:23365609 (+)-schisandrin B multiple interactions ISO RGD:3371 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PPARG mRNA] CTD PMID:31150632 (-)-citrinin decreases activity ISO RGD:69168 6480464 Citrinin results in decreased activity of PPARG protein CTD PMID:27481073 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:69168 6480464 epigallocatechin gallate results in decreased expression of PPARG mRNA CTD PMID:20706672 (20S)-ginsenoside Rh1 multiple interactions EXP 6480464 ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA], ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG protein] CTD PMID:32623698 (25R)-cholest-5-ene-3beta,26-diol increases expression ISO RGD:3371 6480464 27-hydroxycholesterol results in increased expression of PPARG mRNA, 27-hydroxycholesterol results in increased expression of PPARG protein CTD PMID:28167099 (3-phenoxyphenyl)methanol multiple interactions EXP 6480464 3-phenoxybenzylalcohol binds to and results in increased activity of PPARG protein CTD PMID:33049310 (3-phenoxyphenyl)methanol multiple interactions ISO RGD:69168 6480464 3-phenoxybenzylalcohol binds to and results in increased activity of PPARG protein CTD PMID:33049310 (4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosahexaenoic acid multiple interactions EXP 6480464 17-hydroxy-4 more ... CTD PMID:17056761 (R)-carnitine multiple interactions ISO RGD:3371 6480464 Carnitine inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein] CTD PMID:30256492 (R)-carnitine increases expression ISO RGD:3371 6480464 Carnitine results in increased expression of PPARG protein CTD PMID:30256492 (R)-lipoic acid multiple interactions ISO RGD:3371 6480464 [Thioctic Acid co-treated with Dietary Fats] results in increased expression of PPARG mRNA CTD PMID:22464149 (R)-mevalonic acid multiple interactions ISO RGD:3371 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] CTD PMID:20578043 (R)-noradrenaline increases expression ISO RGD:3371 6480464 Norepinephrine results in increased expression of PPARG mRNA CTD PMID:19109942 (R,R,R)-alpha-tocopherol multiple interactions ISO RGD:3371 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 (R,R,R)-alpha-tocopherol increases expression ISO RGD:3371 6480464 alpha-Tocopherol results in increased expression of PPARG protein CTD PMID:11752099 (R,R,R)-alpha-tocopherol increases expression ISO RGD:69168 6480464 alpha-Tocopherol results in increased expression of PPARG mRNA, alpha-Tocopherol results in increased expression of PPARG protein CTD PMID:14521714 , PMID:28062356 (R,R,R)-alpha-tocopherol increases activity ISO RGD:69168 6480464 alpha-Tocopherol results in increased activity of PPARG protein CTD PMID:19083475 (S)-naringenin multiple interactions ISO RGD:3371 6480464 HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:29223569 , PMID:31063766 (S)-naringenin multiple interactions EXP 6480464 naringenin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARG protein] CTD PMID:31063766 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of PPARG protein CTD PMID:33082140 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of PPARG mRNA CTD PMID:31622651 (Z)-ligustilide multiple interactions EXP 6480464 ligustilide inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein] more ... CTD PMID:33130971 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of PPARG mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of PPARG mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPARG mRNA CTD PMID:22206623 1,3-thiazolidine-2,4-dione increases expression ISO RGD:3371 6480464 2, 4-thiazolidinedione results in increased expression of PPARG mRNA CTD PMID:20724125 1,3-thiazolidine-2,4-dione multiple interactions ISO RGD:69168 6480464 2, 4-thiazolidinedione binds to and results in increased activity of PPARG protein CTD PMID:15521013 1,3-thiazolidine-2,4-dione affects binding ISO RGD:69168 6480464 2, 4-thiazolidinedione binds to PPARG protein CTD PMID:15916743 1,4-bis(2-ethylhexyl) sulfosuccinate multiple interactions ISO RGD:69168 6480464 Dioctyl Sulfosuccinic Acid binds to and results in increased activity of PPARG protein CTD PMID:26135921 1,4-bis(2-ethylhexyl) sulfosuccinate increases activity EXP 6480464 Dioctyl Sulfosuccinic Acid results in increased activity of PPARG protein CTD PMID:26135921 1,4-phenylenediamine increases expression ISO RGD:69168 6480464 4-phenylenediamine results in increased expression of PPARG mRNA CTD PMID:16314067 1-Hydroxypyrene multiple interactions EXP 6480464 1-hydroxypyrene binds to and results in increased activity of PPARG protein CTD PMID:33049310 1-Hydroxypyrene multiple interactions ISO RGD:69168 6480464 1-hydroxypyrene binds to and results in increased activity of PPARG protein CTD PMID:33049310 1-naphthyl isothiocyanate decreases expression ISO RGD:3371 6480464 1-Naphthylisothiocyanate results in decreased expression of PPARG mRNA CTD PMID:30723492 10H-phenothiazine multiple interactions EXP 6480464 phenothiazine binds to and results in increased activity of PPARG protein CTD PMID:33049310 10H-phenothiazine multiple interactions ISO RGD:69168 6480464 phenothiazine binds to and results in increased activity of PPARG protein CTD PMID:33049310 13-HPODE increases expression ISO RGD:3371 6480464 13-hydroperoxy-9, 11-octadecadienoic acid results in increased expression of PPARG protein CTD PMID:22135674 14-Deoxy-11,12-didehydroandrographolide multiple interactions EXP 6480464 14-deoxy-11 more ... CTD PMID:30248417 15-acetyldeoxynivalenol decreases activity ISO RGD:69168 6480464 15-acetyldeoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:69168 6480464 15-deoxy-delta(12 more ... CTD PMID:11030710 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 increases activity ISO RGD:69168 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in increased activity of PPARG protein CTD PMID:15707588 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression ISO RGD:69168 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in decreased expression of PPARG protein CTD PMID:17341418 15-deoxy-Delta(12,14)-prostaglandin J2 affects expression ISO RGD:69168 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 affects the expression of PPARG CTD PMID:15254749 15-deoxy-Delta(12,14)-prostaglandin J2 decreases response to substance ISO RGD:69168 6480464 PPARG protein mutant form results in decreased susceptibility to 15-deoxy-delta(12, 14)-prostaglandin J2 CTD PMID:19922793 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression ISO RGD:3371 6480464 15-deoxy-delta(12 more ... CTD PMID:10662598 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 increases activity EXP 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in increased activity of PPARG protein CTD PMID:15322177 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:3371 6480464 15-deoxy-delta(12 more ... CTD PMID:15994020 , PMID:18278065 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:12847270 , PMID:16324150 17alpha-ethynylestradiol multiple interactions EXP 6480464 ESR1 gene mutant form inhibits the reaction [Ethinyl Estradiol results in increased expression of PPARG mRNA] CTD PMID:29112739 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PPARG mRNA CTD PMID:29112739 17beta-estradiol multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]], [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA CTD PMID:19619570 , PMID:21734263 17beta-estradiol affects expression ISO RGD:3371 6480464 Estradiol affects the expression of PPARG mRNA, Estradiol affects the expression of PPARG protein CTD PMID:22389237 17beta-estradiol multiple interactions ISO RGD:3371 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 17beta-estradiol increases expression ISO RGD:69168 6480464 Estradiol results in increased expression of PPARG mRNA CTD PMID:19619570 more ... 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of PPARG mRNA CTD PMID:18359623 17beta-estradiol decreases expression ISO RGD:69168 6480464 Estradiol results in decreased expression of PPARG mRNA CTD PMID:21632903 more ... 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:69168 6480464 Dihydrotestosterone results in decreased expression of PPARG mRNA, Dihydrotestosterone results in decreased expression of PPARG protein CTD PMID:18801408 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of PPARG mRNA CTD PMID:16990341 17beta-hydroxy-5alpha-androstan-3-one decreases expression EXP 6480464 Dihydrotestosterone results in decreased expression of PPARG mRNA, Dihydrotestosterone results in decreased expression of PPARG protein CTD PMID:12960001 1H-pyrazole increases expression EXP 6480464 pyrazole results in increased expression of PPARG mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 , PMID:31449830 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:31449830 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:29112739 , PMID:29523931 2,2',4,4'-Tetrabromodiphenyl ether increases activity ISO RGD:69168 6480464 2 more ... CTD PMID:26172262 , PMID:28282128 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:23398518 2,2',4,4'-Tetrabromodiphenyl ether decreases methylation EXP 6480464 2 more ... CTD PMID:24559133 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:24559133 more ... 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:69168 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,2'-Bisphenol F multiple interactions EXP 6480464 2, 2'-bisphenol F binds to and results in increased activity of PPARG protein CTD PMID:33049310 2,2'-Bisphenol F multiple interactions ISO RGD:69168 6480464 2, 2'-bisphenol F binds to and results in increased activity of PPARG protein CTD PMID:33049310 2,2'-Dihydroxy-4-methoxybenzophenone increases expression ISO RGD:69168 6480464 dioxybenzone results in increased expression of PPARG mRNA CTD PMID:32407875 2,2'-Dihydroxy-4-methoxybenzophenone affects binding ISO RGD:69168 6480464 dioxybenzone binds to PPARG protein CTD PMID:32407875 2,2'-Dihydroxy-4-methoxybenzophenone multiple interactions ISO RGD:69168 6480464 dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA], dioxybenzone promotes the reaction [NCOA2 protein binds to PPARG protein] CTD PMID:32407875 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononanoic acid increases expression EXP 6480464 hexadecafluoro-nonanoic acid results in increased expression of PPARG mRNA CTD PMID:18583369 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA CTD PMID:24058054 , PMID:27713108 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69168 6480464 Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA, Tetrachlorodibenzodioxin results in decreased expression of PPARG protein CTD PMID:12758056 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69168 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] more ... CTD PMID:12758056 more ... 2,4,5-trichlorophenol multiple interactions EXP 6480464 2 more ... CTD PMID:33049310 2,4,5-trichlorophenol multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:33049310 2,4,6-tribromophenol affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,4,6-trichlorophenol affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:3371 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA] more ... CTD PMID:16782535 more ... 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA CTD PMID:21829567 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO RGD:3371 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA, Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein CTD PMID:16782535 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases methylation EXP 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:69168 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:30903904 2,4-dinitrotoluene increases expression EXP 6480464 2, 4-dinitrotoluene results in increased expression of PPARG mRNA CTD PMID:24893713 2,4-dinitrotoluene increases activity EXP 6480464 2, 4-dinitrotoluene results in increased activity of PPARG protein CTD PMID:24893713 2,5-di-tert-butylbenzene-1,4-diol multiple interactions ISO RGD:69168 6480464 2, 5-di-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 2,5-di-tert-butylbenzene-1,4-diol multiple interactions EXP 6480464 2, 5-di-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 2,6-di-tert-butyl-4-methylphenol increases expression EXP 6480464 Butylated Hydroxytoluene results in increased expression of PPARG mRNA CTD PMID:19925653 2,6-di-tert-butyl-4-methylphenol multiple interactions ISO RGD:69168 6480464 Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of PPARG mRNA] CTD PMID:17070507 2,6-diisopropylnaphthalene multiple interactions ISO RGD:69168 6480464 2, 6-diisopropylnaphthalene binds to and results in increased activity of PPARG protein CTD PMID:27633901 2-amino-2-deoxy-D-galactopyranose multiple interactions EXP 6480464 [lipopolysaccharide more ... CTD PMID:30236599 , PMID:30550845 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:69168 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:3371 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:69168 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 2-amino-2-deoxy-D-glucopyranose 6-phosphate decreases expression EXP 6480464 glucosamine 6-phosphate results in decreased expression of PPARG protein CTD PMID:19427183 2-arachidonoylglycerol affects binding ISO RGD:69168 6480464 glyceryl 2-arachidonate metabolite binds to PPARG protein CTD PMID:21511917 2-arachidonoylglycerol multiple interactions EXP 6480464 glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein] more ... CTD PMID:26209559 2-arachidonoylglycerol multiple interactions ISO RGD:69168 6480464 T 0070907 inhibits the reaction [glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA] CTD PMID:21511917 2-arachidonoylglycerol increases expression ISO RGD:69168 6480464 glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA CTD PMID:21511917 2-bromohexadecanoic acid increases expression ISO RGD:3371 6480464 2-bromopalmitate results in increased expression of PPARG protein CTD PMID:10650946 2-deoxy-D-glucose affects uptake EXP 6480464 PPARG protein affects the uptake of Deoxyglucose CTD PMID:18083318 2-deoxy-D-glucose increases uptake EXP 6480464 PPARG gene polymorphism results in increased uptake of Deoxyglucose CTD PMID:18083318 2-Ethylhexanoic acid increases expression ISO RGD:3371 6480464 2-ethylhexanoic acid results in increased expression of PPARG mRNA, 2-ethylhexanoic acid results in increased expression of PPARG protein CTD PMID:15647598 2-Ethylhexyl acrylate multiple interactions ISO RGD:69168 6480464 2-ethylhexyl acrylate binds to and results in increased activity of PPARG protein CTD PMID:27633901 2-tert-butylhydroquinone multiple interactions ISO RGD:69168 6480464 2-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 2-tert-butylhydroquinone multiple interactions EXP 6480464 2-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO RGD:3371 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] CTD PMID:20578043 25-hydroxycholesterol multiple interactions ISO RGD:69168 6480464 [9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA], [9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol] CTD PMID:12595494 26-hydroxycholesterol increases expression ISO RGD:3371 6480464 27-hydroxycholesterol results in increased expression of PPARG mRNA, 27-hydroxycholesterol results in increased expression of PPARG protein CTD PMID:28167099 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions ISO RGD:3371 6480464 pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein] CTD PMID:16598202 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression ISO RGD:3371 6480464 Puromycin Aminonucleoside results in increased expression of PPARG protein CTD PMID:16598202 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:69168 6480464 3 more ... CTD PMID:25304490 , PMID:35618242 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:28973532 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:69168 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [3 more ... CTD PMID:25304490 3,3',4,4'-tetrachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:30935970 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:69168 6480464 tetrabromobisphenol A binds to and results in increased activity of PPARG protein more ... CTD PMID:21561829 more ... 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:3371 6480464 tetrabromobisphenol A inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA] CTD PMID:25048947 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:69168 6480464 tetrabromobisphenol A results in increased expression of PPARG mRNA CTD PMID:32473317 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [tetrabromobisphenol A results in decreased expression of PPARG protein] more ... CTD PMID:24132472 more ... 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of PPARG protein CTD PMID:24132472 3,3',5,5'-tetrabromobisphenol A affects binding ISO RGD:69168 6480464 tetrabromobisphenol A binds to PPARG protein CTD PMID:25314719 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of PPARG mRNA CTD PMID:25863188 , PMID:30496566 3,3',5,5'-tetrabromobisphenol A increases activity EXP 6480464 tetrabromobisphenol A results in increased activity of PPARG protein CTD PMID:25777084 more ... 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:3371 6480464 tetrabromobisphenol A results in decreased expression of PPARG mRNA CTD PMID:26988606 3,3',5,5'-tetrabromobisphenol A increases activity ISO RGD:69168 6480464 tetrabromobisphenol A results in increased activity of PPARG protein CTD PMID:24591153 more ... 3,3',5,5'-tetraiodothyroacetic acid multiple interactions EXP 6480464 tetraiodothyroacetic acid binds to and results in increased activity of PPARG protein CTD PMID:33049310 3,3',5,5'-tetraiodothyroacetic acid multiple interactions ISO RGD:69168 6480464 tetraiodothyroacetic acid binds to and results in increased activity of PPARG protein CTD PMID:33049310 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:69168 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA more ... CTD PMID:33049310 , PMID:33476690 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:3371 6480464 Triiodothyronine inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA] CTD PMID:25048947 3,3',5-triiodo-L-thyronine multiple interactions EXP 6480464 Triiodothyronine binds to and results in increased activity of PPARG protein CTD PMID:33049310 3,3'-Dimethylbenzidine multiple interactions ISO RGD:69168 6480464 2-tolidine binds to and results in increased activity of PPARG protein CTD PMID:33049310 3,3'-Dimethylbenzidine multiple interactions EXP 6480464 2-tolidine binds to and results in increased activity of PPARG protein CTD PMID:33049310 3,4-Dimethylbenzaldehyde multiple interactions ISO RGD:69168 6480464 3, 4-dimethylbenzaldehyde binds to and results in decreased activity of PPARG protein CTD PMID:27633901 3,5,6-trichloro-2-pyridinol multiple interactions EXP 6480464 3 more ... CTD PMID:32017950 3,5,6-trichloropyridine-2-one multiple interactions EXP 6480464 3 more ... CTD PMID:32017950 3,5-di-tert-Butyl-4-hydroxybenzaldehyde multiple interactions ISO RGD:69168 6480464 3, 5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of PPARG protein CTD PMID:27633901 3,6-diaminoacridine multiple interactions ISO RGD:69168 6480464 Proflavine inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid increases expression ISO RGD:69168 6480464 MK-886 results in increased expression of PPARG mRNA CTD PMID:15899809 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid affects localization ISO RGD:69168 6480464 MK-886 affects the localization of PPARG protein CTD PMID:15899809 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:69168 6480464 [Indomethacin co-treated with MK-886] affects the localization of PPARG protein, Indomethacin promotes the reaction [MK-886 results in increased activity of PPARG protein] CTD PMID:15899809 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid increases activity ISO RGD:69168 6480464 MK-886 results in increased activity of PPARG protein CTD PMID:15899809 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:69168 6480464 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] CTD PMID:16945329 3-acetyldeoxynivalenol decreases activity ISO RGD:69168 6480464 3-acetyldeoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 3-aminobenzamide increases activity ISO RGD:3371 6480464 3-aminobenzamide results in increased activity of PPARG protein CTD PMID:18815186 3-aminobenzamide multiple interactions ISO RGD:3371 6480464 3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein] CTD PMID:18815186 3-aminobenzamide decreases ADP-ribosylation ISO RGD:3371 6480464 3-aminobenzamide results in decreased ADP-ribosylation of PPARG protein CTD PMID:18815186 3-iodoprop-2-yn-1-yl butylcarbamate multiple interactions ISO RGD:69168 6480464 3-iodo-2-propynylbutylcarbamate binds to and results in increased activity of PPARG protein CTD PMID:33049310 3-iodoprop-2-yn-1-yl butylcarbamate multiple interactions EXP 6480464 3-iodo-2-propynylbutylcarbamate binds to and results in increased activity of PPARG protein CTD PMID:33049310 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein] more ... CTD PMID:11101056 more ... 3-isobutyl-1-methyl-7H-xanthine increases expression ISO RGD:69168 6480464 1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA CTD PMID:22645054 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:3371 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA CTD PMID:21350315 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69168 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Firemaster 550] results in increased expression of PPARG mRNA more ... CTD PMID:19186324 more ... 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one multiple interactions EXP 6480464 alpha-isomethylionone binds to and results in increased activity of PPARG protein CTD PMID:33049310 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one multiple interactions ISO RGD:69168 6480464 alpha-isomethylionone binds to and results in increased activity of PPARG protein CTD PMID:33049310 3-phenylprop-2-enal decreases expression EXP 6480464 cinnamaldehyde results in decreased expression of PPARG mRNA CTD PMID:21401097 4'-Methoxychalcone multiple interactions EXP 6480464 4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA], 4'-methoxychalcone analog results in increased expression of and results in increased activity of PPARG protein CTD PMID:28528971 4'-Methoxychalcone increases expression EXP 6480464 4'-methoxychalcone analog results in increased expression of PPARG mRNA CTD PMID:28528971 4,4'-sulfonyldiphenol increases expression ISO RGD:69168 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PPARG mRNA CTD PMID:27003841 , PMID:31778932 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PPARG mRNA CTD PMID:30951980 , PMID:30959087 4,4'-sulfonyldiphenol increases activity ISO RGD:69168 6480464 bis(4-hydroxyphenyl)sulfone analog results in increased activity of PPARG protein, bis(4-hydroxyphenyl)sulfone results in increased activity of PPARG protein CTD PMID:29331639 4,4'-sulfonyldiphenol multiple interactions ISO RGD:69168 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] affects the expression of PPARG protein more ... CTD PMID:27633901 more ... 4,4'-sulfonyldiphenol increases activity EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased activity of PPARG protein CTD PMID:27273607 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:27241191 more ... 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of PPARG protein CTD PMID:22200888 4-(ethoxymethylene)-2-phenyloxazol-5-one multiple interactions EXP 6480464 tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein] CTD PMID:22200888 4-chloro-3,5-dimethylphenol multiple interactions EXP 6480464 chloroxylenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 4-chloro-3,5-dimethylphenol multiple interactions ISO RGD:69168 6480464 chloroxylenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 4-hydroxynon-2-enal decreases expression ISO RGD:69168 6480464 4-hydroxy-2-nonenal results in decreased expression of PPARG protein CTD PMID:27417252 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of PPARG mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases activity ISO RGD:69168 6480464 Fenretinide results in increased activity of PPARG protein CTD PMID:16274795 4-Methyl-3-penten-2-one, 9CI multiple interactions ISO RGD:69168 6480464 mesityl oxide binds to and results in decreased activity of PPARG protein CTD PMID:33049310 4-nonylphenol increases expression ISO RGD:3371 6480464 4-nonylphenol results in increased expression of PPARG mRNA CTD PMID:24388992 5-aza-2'-deoxycytidine affects expression ISO RGD:69168 6480464 Decitabine affects the expression of PPARG mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine increases expression ISO RGD:69168 6480464 Decitabine results in increased expression of PPARG mRNA CTD PMID:16763620 5-azacytidine decreases methylation EXP 6480464 Azacitidine results in decreased methylation of PPARG promoter CTD PMID:19589179 5-azacytidine increases expression EXP 6480464 Azacitidine results in increased expression of PPARG mRNA CTD PMID:19589179 5-fluorouracil decreases expression ISO RGD:69168 6480464 Fluorouracil results in decreased expression of PPARG protein CTD PMID:15352031 5-fluorouracil affects response to substance ISO RGD:69168 6480464 PPARG protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-formyltetrahydrofolic acid multiple interactions ISO RGD:3371 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of PPARG mRNA, [Methotrexate co-treated with Leucovorin] results in increased expression of PPARG protein CTD PMID:25187349 6-propyl-2-thiouracil decreases expression ISO RGD:3371 6480464 Propylthiouracil results in decreased expression of PPARG mRNA CTD PMID:24780913 7,12-dimethyltetraphene multiple interactions EXP 6480464 9 more ... CTD PMID:33049310 7,12-dimethyltetraphene multiple interactions ISO RGD:69168 6480464 9 more ... CTD PMID:33049310 8-(4-chlorophenylthio)-cGMP multiple interactions EXP 6480464 8-(4-chlorophenylthio)guanosine 3' more ... CTD PMID:20471953 8-(4-chlorophenylthio)-cGMP increases expression EXP 6480464 8-((4-chlorophenyl)thio)cyclic-3', 5'-GMP results in increased expression of PPARG protein CTD PMID:20471953 8-Br-cAMP decreases expression ISO RGD:3371 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPARG mRNA CTD PMID:15994020 8-Br-cAMP multiple interactions ISO RGD:3371 6480464 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA] CTD PMID:15994020 9,10-epoxy-12-octadecenoic acid affects binding EXP 6480464 9, 10-epoxy-12-octadecenoic acid binds to PPARG protein CTD PMID:12021203 9,11,13-octadecatrienoic acid increases expression ISO RGD:69168 6480464 eleostearic acid results in increased expression of PPARG mRNA, eleostearic acid results in increased expression of PPARG protein CTD PMID:15961301 9-cis-retinoic acid multiple interactions ISO RGD:69168 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Alitretinoin results in increased activity of PPARG protein], MG 262 promotes the reaction [Alitretinoin results in increased activity of PPARG protein] CTD PMID:15707588 9-cis-retinoic acid multiple interactions ISO RGD:3371 6480464 [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter], Alitretinoin binds to and results in increased activity of PPARG protein CTD PMID:15150131 , PMID:18063688 9-cis-retinoic acid increases activity ISO RGD:69168 6480464 Alitretinoin results in increased activity of PPARG protein CTD PMID:15707588 9-cis-retinoic acid multiple interactions EXP 6480464 [Pioglitazone co-treated with Alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine], PPARG protein promotes the reaction [Alitretinoin results in increased expression of PPARGC1A mRNA] CTD PMID:16513826 , PMID:17019405 9-HODE increases expression ISO RGD:69168 6480464 9-hydroxy-10, 12-octadecadienoic acid results in increased expression of PPARG CTD PMID:16647253 9-phenanthrol multiple interactions ISO RGD:69168 6480464 9-phenanthrol binds to and results in increased activity of PPARG protein CTD PMID:33049310 9-phenanthrol multiple interactions EXP 6480464 9-phenanthrol binds to and affects the activity of PPARG protein CTD PMID:33049310 9E,11E-octadecadienoic acid affects binding ISO RGD:69168 6480464 9, 11-linoleic acid binds to PPARG protein CTD PMID:23843199 9E,11E-octadecadienoic acid increases activity ISO RGD:69168 6480464 9, 11-linoleic acid results in increased activity of PPARG protein CTD PMID:18155510 [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID multiple interactions EXP 6480464 3 more ... CTD PMID:33049310 [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID multiple interactions ISO RGD:69168 6480464 3 more ... CTD PMID:33049310 [6]-Shogaol increases activity EXP 6480464 shogaol results in increased activity of PPARG protein CTD PMID:18577375 AACOCF3 multiple interactions EXP 6480464 arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA] CTD PMID:19063610 acetaldehyde multiple interactions ISO RGD:69168 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] more ... CTD PMID:17030193 acetic acid decreases expression ISO RGD:3371 6480464 Acetic Acid results in decreased expression of PPARG protein CTD PMID:32045587 acetic acid multiple interactions ISO RGD:3371 6480464 Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of PPARG protein] CTD PMID:32045587 acetochlor multiple interactions ISO RGD:69168 6480464 acetochlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 acetochlor multiple interactions EXP 6480464 acetochlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 acetophenone multiple interactions ISO RGD:69168 6480464 acetophenone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 acetylsalicylic acid decreases activity ISO RGD:69168 6480464 Aspirin results in decreased activity of PPARG protein CTD PMID:15646027 acetylsalicylic acid decreases expression ISO RGD:3371 6480464 Aspirin results in decreased expression of PPARG mRNA CTD PMID:18222077 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of PPARG mRNA CTD PMID:19462226 acetylsalicylic acid increases expression ISO RGD:69168 6480464 Aspirin results in increased expression of PPARG more ... CTD PMID:18971601 , PMID:19880272 acetylsalicylic acid multiple interactions ISO RGD:69168 6480464 Aspirin inhibits the reaction [Niacin results in increased activity of PPARG protein] CTD PMID:16386710 acrolein multiple interactions ISO RGD:69168 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA CTD PMID:32699268 acrolein multiple interactions EXP 6480464 [Acrolein promotes the reaction [DDIT3 protein binds to PPARG promoter]] which results in decreased expression of PPARG protein more ... CTD PMID:34813903 acrolein decreases expression EXP 6480464 Acrolein results in decreased expression of PPARG protein CTD PMID:34813903 acrylamide multiple interactions EXP 6480464 Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA] more ... CTD PMID:30409764 adefovir pivoxil affects activity ISO RGD:69168 6480464 adefovir dipivoxil affects the activity of PPARG protein CTD PMID:25596134 afimoxifene multiple interactions ISO RGD:69168 6480464 afimoxifene binds to and results in increased activity of PPARG protein more ... CTD PMID:27358406 , PMID:33049310 afimoxifene multiple interactions EXP 6480464 afimoxifene binds to and results in increased activity of PPARG protein, PPARG mRNA promotes the reaction [afimoxifene results in decreased expression of CD36 protein] CTD PMID:27358406 , PMID:33049310 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PPARG mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:69168 6480464 Aflatoxin B1 results in decreased methylation of PPARG gene CTD PMID:27153756 AICA ribonucleotide multiple interactions ISO RGD:3371 6480464 AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] CTD PMID:25108154 AICA ribonucleotide multiple interactions ISO RGD:69168 6480464 AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein] CTD PMID:27688165 AL 8810 increases expression EXP 6480464 AL 8810 results in increased expression of PPARG mRNA CTD PMID:21236357 aldehydo-D-glucosamine multiple interactions ISO RGD:69168 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 aldehydo-D-glucosamine increases expression ISO RGD:3371 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 aldehydo-D-glucosamine increases expression ISO RGD:69168 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 aldehydo-D-glucosamine 6-phosphate decreases expression EXP 6480464 glucosamine 6-phosphate results in decreased expression of PPARG protein CTD PMID:19427183 aldehydo-D-glucose multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 more ... aldehydo-D-glucose decreases expression ISO RGD:3371 6480464 Glucose results in decreased expression of PPARG mRNA, Glucose results in decreased expression of PPARG protein CTD PMID:19609456 , PMID:31063766 aldehydo-D-glucose multiple interactions ISO RGD:3371 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... aldehydo-D-glucose decreases expression ISO RGD:69168 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 aldosterone affects abundance EXP 6480464 PPARG protein affects the abundance of Aldosterone CTD PMID:16007095 all-trans-retinoic acid multiple interactions ISO RGD:69168 6480464 [Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of PPARG mRNA more ... CTD PMID:16982809 more ... all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA] CTD PMID:32473317 all-trans-retinoic acid increases expression ISO RGD:69168 6480464 Tretinoin results in increased expression of PPARG mRNA CTD PMID:21934132 , PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:3371 6480464 Tretinoin results in increased expression of PPARG mRNA, Tretinoin results in increased expression of PPARG protein CTD PMID:14568882 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PPARG mRNA CTD PMID:17198874 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of PPARG mRNA CTD PMID:11237167 all-trans-retinol multiple interactions ISO RGD:3371 6480464 Vitamin A inhibits the reaction [Safflower Oil results in increased expression of PPARG mRNA] CTD PMID:15203375 all-trans-retinol increases expression ISO RGD:3371 6480464 Vitamin A results in increased expression of PPARG mRNA CTD PMID:16180333 allethrin increases expression ISO RGD:69168 6480464 Allethrins results in increased expression of PPARG mRNA CTD PMID:32473317 allethrin increases activity ISO RGD:69168 6480464 Allethrins results in increased activity of PPARG protein CTD PMID:20143881 allyl isothiocyanate multiple interactions ISO RGD:3371 6480464 allyl isothiocyanate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG protein], allyl isothiocyanate inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein] CTD PMID:30927557 Aloe emodin multiple interactions ISO RGD:69168 6480464 aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA] CTD PMID:22645054 alpha-linolenic acid increases expression EXP 6480464 alpha-Linolenic Acid results in increased expression of PPARG mRNA CTD PMID:18154422 alpha-linolenic acid increases activity ISO RGD:69168 6480464 alpha-Linolenic Acid results in increased activity of PPARG protein CTD PMID:20696231 alpha-linolenic acid multiple interactions ISO RGD:69168 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 alpha-linolenic acid multiple interactions EXP 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 alpha-linolenic acid multiple interactions ISO RGD:3371 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 alpha-pinene multiple interactions ISO RGD:69168 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA CTD PMID:32699268 amentoflavone multiple interactions ISO RGD:69168 6480464 amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein more ... CTD PMID:34599948 amiodarone multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of FADS2 mRNA] more ... CTD PMID:21123845 , PMID:24489787 amiodarone increases expression ISO RGD:69168 6480464 Amiodarone results in increased expression of PPARG mRNA CTD PMID:21123845 ammonium chloride affects expression ISO RGD:3371 6480464 Ammonium Chloride affects the expression of PPARG mRNA CTD PMID:16483693 andrographolide multiple interactions EXP 6480464 andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein] CTD PMID:27475717 androst-4-ene-3,17-dione multiple interactions ISO RGD:69168 6480464 Androstenedione binds to and results in decreased activity of PPARG protein CTD PMID:33049310 androst-4-ene-3,17-dione multiple interactions EXP 6480464 Androstenedione binds to and results in decreased activity of PPARG protein CTD PMID:33049310 anthra[1,9-cd]pyrazol-6(2H)-one increases expression ISO RGD:3371 6480464 pyrazolanthrone results in increased expression of PPARG mRNA, pyrazolanthrone results in increased expression of PPARG protein CTD PMID:17372590 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:3371 6480464 pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein] CTD PMID:28283887 apigenin multiple interactions EXP 6480464 Apigenin binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 , PMID:33049310 apigenin multiple interactions ISO RGD:69168 6480464 Apigenin binds to and results in increased activity of PPARG protein CTD PMID:33049310 apigenin decreases expression EXP 6480464 Apigenin results in decreased expression of PPARG mRNA CTD PMID:18359623 arachidonic acid decreases expression ISO RGD:69168 6480464 Arachidonic Acid results in decreased expression of PPARG mRNA, Arachidonic Acid results in decreased expression of PPARG protein CTD PMID:11172467 arachidonic acid multiple interactions EXP 6480464 Arachidonic Acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA] CTD PMID:19063610 arachidonic acid increases expression ISO RGD:3371 6480464 Arachidonic Acid results in increased expression of PPARG protein CTD PMID:12604186 Aroclor 1254 increases expression ISO RGD:69168 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of PPARG mRNA CTD PMID:16934159 Aroclor 1254 multiple interactions EXP 6480464 [Diethylhexyl Phthalate co-treated with Chlorodiphenyl (54% Chlorine)] results in increased expression of PPARG mRNA CTD PMID:23804495 arsane decreases expression ISO RGD:69168 6480464 Arsenic results in decreased expression of PPARG mRNA, Arsenic results in decreased expression of PPARG protein CTD PMID:23108036 arsane affects expression ISO RGD:69168 6480464 Arsenic affects the expression of PPARG mRNA CTD PMID:28793237 arsane multiple interactions ISO RGD:69168 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA more ... CTD PMID:23108036 , PMID:28793237 arsenic atom decreases expression ISO RGD:69168 6480464 Arsenic results in decreased expression of PPARG mRNA, Arsenic results in decreased expression of PPARG protein CTD PMID:23108036 arsenic atom affects expression ISO RGD:69168 6480464 Arsenic affects the expression of PPARG mRNA CTD PMID:28793237 arsenic atom multiple interactions ISO RGD:69168 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA more ... CTD PMID:23108036 , PMID:28793237 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of PPARG mRNA CTD PMID:15868481 arsenous acid decreases response to substance ISO RGD:69168 6480464 PPARG protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 arsenous acid decreases expression ISO RGD:3371 6480464 Arsenic Trioxide results in decreased expression of PPARG mRNA CTD PMID:31258454 arsenous acid decreases expression ISO RGD:69168 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:30362509 arsenous acid increases expression ISO RGD:69168 6480464 Arsenic Trioxide results in increased expression of PPARG mRNA, Arsenic Trioxide results in increased expression of PPARG protein CTD PMID:22684020 arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein] more ... CTD PMID:15916724 , PMID:30362509 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:15916724 , PMID:30362509 arsenous acid multiple interactions ISO RGD:69168 6480464 [Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide more ... CTD PMID:22684020 more ... aspartame multiple interactions EXP 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA CTD PMID:23783067 ATP multiple interactions ISO RGD:69168 6480464 FASN protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]] more ... CTD PMID:26670611 ATP decreases abundance ISO RGD:69168 6480464 PPARG protein mutant form results in decreased abundance of Adenosine Triphosphate, PPARG protein results in decreased abundance of Adenosine Triphosphate CTD PMID:26670611 atrazine multiple interactions EXP 6480464 Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA] CTD PMID:24440342 atrazine multiple interactions ISO RGD:69168 6480464 [Atrazine co-treated with Arsenates] results in increased expression of PPARG mRNA CTD PMID:18585445 Aurothioglucose multiple interactions EXP 6480464 [Dietary Fats co-treated with Aurothioglucose] results in decreased expression of PPARG protein CTD PMID:21382165 avobenzone multiple interactions ISO RGD:69168 6480464 avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA], avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] CTD PMID:31016361 , PMID:32407875 avobenzone increases expression ISO RGD:69168 6480464 avobenzone results in increased expression of PPARG mRNA CTD PMID:31016361 , PMID:32407875 azinphos-methyl multiple interactions ISO RGD:69168 6480464 Azinphosmethyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 azinphos-methyl multiple interactions EXP 6480464 Azinphosmethyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 baicalein decreases expression EXP 6480464 baicalein results in decreased expression of PPARG protein CTD PMID:24560969 baicalin multiple interactions ISO RGD:3371 6480464 baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein] CTD PMID:24312512 Bardoxolone methyl increases expression EXP 6480464 bardoxolone methyl results in increased expression of PPARG mRNA, bardoxolone methyl results in increased expression of PPARG protein CTD PMID:21289052 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of PPARG mRNA CTD PMID:19048458 benzene increases expression ISO RGD:69168 6480464 Benzene results in increased expression of PPARG mRNA CTD PMID:19162166 benzo[a]pyrene decreases expression ISO RGD:69168 6480464 Benzo(a)pyrene results in decreased expression of PPARG mRNA CTD PMID:20064835 , PMID:30453624 benzo[a]pyrene decreases expression ISO RGD:3371 6480464 Benzo(a)pyrene results in decreased expression of PPARG protein CTD PMID:34999049 benzo[a]pyrene multiple interactions ISO RGD:69168 6480464 [Soot co-treated with Benzo(a)pyrene] results in decreased activity of PPARG protein CTD PMID:24464499 benzo[a]pyrene multiple interactions EXP 6480464 Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein] more ... CTD PMID:27329536 benzo[a]pyrene increases activity EXP 6480464 Benzo(a)pyrene results in increased activity of PPARG protein CTD PMID:27329536 benzo[a]pyrene increases expression ISO RGD:3371 6480464 Benzo(a)pyrene results in increased expression of PPARG mRNA, Benzo(a)pyrene results in increased expression of PPARG protein CTD PMID:20920559 , PMID:22374506 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PPARG mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PPARG mRNA CTD PMID:19770486 benzo[a]pyrene multiple interactions ISO RGD:3371 6480464 [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA more ... CTD PMID:20920559 , PMID:34999049 benzo[a]pyrene increases expression ISO RGD:69168 6480464 Benzo(a)pyrene results in increased expression of PPARG mRNA CTD PMID:15735009 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:69168 6480464 7 more ... CTD PMID:19150397 benzofurans decreases expression EXP 6480464 Benzofurans results in decreased expression of PPARG mRNA, Benzofurans results in decreased expression of PPARG protein CTD PMID:20863820 Benzyl parahydroxybenzoate increases expression EXP 6480464 benzylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 , PMID:27659731 Benzyl parahydroxybenzoate increases activity EXP 6480464 benzylparaben results in increased activity of PPARG protein CTD PMID:28527915 berberine multiple interactions EXP 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA] more ... CTD PMID:20564506 berberine increases expression ISO RGD:69168 6480464 Berberine results in increased expression of PPARG mRNA CTD PMID:29408570 berberine multiple interactions ISO RGD:69168 6480464 15-deoxyprostaglandin J2 promotes the reaction [Berberine affects the localization of and results in increased activity of PPARG protein] more ... CTD PMID:29408570 berberine increases response to substance ISO RGD:69168 6480464 PPARG mRNA results in increased susceptibility to Berberine CTD PMID:29408570 berberine decreases expression ISO RGD:69168 6480464 Berberine results in decreased expression of PPARG mRNA CTD PMID:26478571 Bergenin multiple interactions ISO RGD:69168 6480464 bergenin inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein], PPARG protein promotes the reaction [bergenin inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]] CTD PMID:34499403 beta-carotene decreases expression EXP 6480464 beta Carotene results in decreased expression of PPARG mRNA CTD PMID:21569430 beta-D-glucosamine multiple interactions ISO RGD:69168 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 beta-D-glucosamine increases expression ISO RGD:3371 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 beta-D-glucosamine increases expression ISO RGD:69168 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 beta-D-glucosamine 6-sulfate decreases expression EXP 6480464 glucosamine 6-O-sulfate results in decreased expression of PPARG mRNA, glucosamine 6-O-sulfate results in decreased expression of PPARG protein CTD PMID:19520133 beta-naphthoflavone multiple interactions EXP 6480464 beta-Naphthoflavone inhibits the reaction [Triclosan results in increased expression of PPARG protein] CTD PMID:33722737 beta-tocopherol multiple interactions ISO RGD:3371 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 bezafibrate multiple interactions EXP 6480464 PPARA protein affects the reaction [Bezafibrate results in increased expression of PPARG mRNA] CTD PMID:21324916 bezafibrate increases expression ISO RGD:69168 6480464 Bezafibrate results in increased expression of PPARG mRNA CTD PMID:19201410 , PMID:24759758 bezafibrate affects binding ISO RGD:69168 6480464 Bezafibrate binds to PPARG protein CTD PMID:11779144 , PMID:23843199 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of PPARG mRNA CTD PMID:19201410 , PMID:21324916 bezafibrate increases activity EXP 6480464 Bezafibrate results in increased activity of PPARG protein CTD PMID:12401884 bezafibrate decreases expression ISO RGD:69168 6480464 Bezafibrate results in decreased expression of PPARG mRNA CTD PMID:15708366 bezafibrate multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]] more ... CTD PMID:11779144 , PMID:21734263 bezafibrate multiple interactions ISO RGD:3371 6480464 Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA] CTD PMID:12967931 bezafibrate decreases expression ISO RGD:3371 6480464 Bezafibrate results in decreased expression of PPARG mRNA CTD PMID:11473052 bicalutamide multiple interactions ISO RGD:69168 6480464 bicalutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 bicalutamide multiple interactions EXP 6480464 bicalutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 bifenthrin multiple interactions EXP 6480464 bifenthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 bifenthrin increases expression ISO RGD:69168 6480464 bifenthrin results in increased expression of PPARG mRNA CTD PMID:29554630 bifenthrin multiple interactions ISO RGD:69168 6480464 bifenthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 biochanin A multiple interactions EXP 6480464 biochanin A binds to and results in increased activity of PPARG protein CTD PMID:33049310 biphenyl-4-ol multiple interactions ISO RGD:69168 6480464 4-phenylphenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 biphenyl-4-ol multiple interactions EXP 6480464 4-phenylphenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:3371 6480464 [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA, [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG protein CTD PMID:20920559 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of PPARG mRNA, Diethylhexyl Phthalate results in decreased expression of PPARG protein CTD PMID:29669060 , PMID:31211961 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PPARG protein] more ... CTD PMID:27633901 more ... bis(2-ethylhexyl) phthalate increases expression ISO RGD:69168 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA, Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:28025108 more ... bis(2-ethylhexyl) phthalate affects binding ISO RGD:69168 6480464 Diethylhexyl Phthalate binds to PPARG protein, Diethylhexyl Phthalate metabolite binds to PPARG protein CTD PMID:23843199 more ... bis(2-ethylhexyl) phthalate affects expression EXP 6480464 Diethylhexyl Phthalate affects the expression of PPARG mRNA CTD PMID:22588786 , PMID:25351189 bis(2-ethylhexyl) phthalate increases expression ISO RGD:3371 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA, Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:15647598 more ... bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA, Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:21856391 more ... bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:22197818 more ... bis(2-ethylhexyl) phthalate decreases expression ISO RGD:3371 6480464 Diethylhexyl Phthalate results in decreased expression of PPARG protein CTD PMID:16690193 , PMID:29669060 bisdemethoxycurcumin affects binding ISO RGD:69168 6480464 bisdemethoxycurcumin binds to PPARG protein CTD PMID:15713005 bismuth atom multiple interactions ISO RGD:69168 6480464 [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of PPARG mRNA CTD PMID:34560244 bismuthane multiple interactions ISO RGD:69168 6480464 [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of PPARG mRNA CTD PMID:34560244 bisphenol A increases localization ISO RGD:69168 6480464 bisphenol A results in increased localization of PPARG protein CTD PMID:20064783 bisphenol A decreases methylation ISO RGD:69168 6480464 bisphenol A results in decreased methylation of PPARG gene CTD PMID:31601247 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of PPARG promoter CTD PMID:33203037 bisphenol A decreases methylation ISO RGD:3371 6480464 bisphenol A results in decreased methylation of PPARG gene CTD PMID:32701268 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PPARG mRNA CTD PMID:30133442 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PPARG protein CTD PMID:31319301 bisphenol A decreases expression ISO RGD:69168 6480464 bisphenol A results in decreased expression of PPARG mRNA CTD PMID:28711546 bisphenol A increases methylation ISO RGD:3371 6480464 bisphenol A results in increased methylation of PPARG gene CTD PMID:28505145 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of PPARG promoter CTD PMID:27334623 bisphenol A increases activity EXP 6480464 bisphenol A results in increased activity of PPARG protein CTD PMID:27273607 bisphenol A decreases expression ISO RGD:3371 6480464 bisphenol A results in decreased expression of PPARG mRNA CTD PMID:23399309 more ... bisphenol A affects binding ISO RGD:69168 6480464 bisphenol A analog binds to PPARG protein, bisphenol A binds to PPARG protein CTD PMID:23843199 more ... bisphenol A increases expression ISO RGD:69168 6480464 bisphenol A analog results in increased expression of PPARG mRNA more ... CTD PMID:20064783 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PPARG more ... CTD PMID:18359623 more ... bisphenol A multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA] more ... CTD PMID:21622942 more ... bisphenol A multiple interactions ISO RGD:3371 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of PPARG protein more ... CTD PMID:23399309 more ... bisphenol A increases expression ISO RGD:3371 6480464 bisphenol A results in increased expression of PPARG mRNA CTD PMID:20019905 more ... bisphenol A multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of PPARG protein more ... CTD PMID:22197818 more ... Bisphenol A diglycidyl ether multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:11030710 more ... Bisphenol A diglycidyl ether decreases activity ISO RGD:3371 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein CTD PMID:27363640 Bisphenol A diglycidyl ether decreases expression ISO RGD:3371 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in decreased expression of PPARG protein CTD PMID:22726273 Bisphenol A diglycidyl ether decreases activity ISO RGD:69168 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein CTD PMID:21543282 Bisphenol A diglycidyl ether multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:19903033 more ... Bisphenol A diglycidyl ether increases expression EXP 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in increased expression of PPARG mRNA CTD PMID:11991651 Bisphenol A diglycidyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:11991651 more ... bisphenol F multiple interactions ISO RGD:69168 6480464 4 more ... CTD PMID:30138673 , PMID:33865937 bisphenol F diglycidyl ether multiple interactions ISO RGD:69168 6480464 bisphenol F diglycidyl ether inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30138673 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of PPARG mRNA, Bleomycin results in decreased expression of PPARG protein CTD PMID:19147827 , PMID:27153807 bleomycin A2 multiple interactions ISO RGD:69168 6480464 Berberine inhibits the reaction [Bleomycin binds to PPARG protein] CTD PMID:29408570 bleomycin A2 multiple interactions EXP 6480464 lenabasum inhibits the reaction [Bleomycin results in decreased expression of PPARG protein], Rosiglitazone inhibits the reaction [Bleomycin results in decreased expression of PPARG mRNA] CTD PMID:19147827 , PMID:27153807 bongkrekic acid increases activity ISO RGD:69168 6480464 Bongkrekic Acid analog results in increased activity of PPARG protein, Bongkrekic Acid results in increased activity of PPARG protein CTD PMID:25786526 boric acid multiple interactions EXP 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA] more ... CTD PMID:28285642 bosentan decreases expression ISO RGD:69168 6480464 Bosentan results in decreased expression of PPARG mRNA CTD PMID:29761207 Bromadiolone multiple interactions EXP 6480464 bromadiolone binds to and results in increased activity of PPARG protein CTD PMID:33049310 Bromadiolone multiple interactions ISO RGD:69168 6480464 bromadiolone binds to and results in increased activity of PPARG protein CTD PMID:33049310 bromuconazole multiple interactions EXP 6480464 bromuconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 bromuconazole multiple interactions ISO RGD:69168 6480464 bromuconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 bucladesine increases expression EXP 6480464 Bucladesine results in increased expression of PPARG protein CTD PMID:19698295 bucladesine multiple interactions EXP 6480464 [ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA, [ciglitazone co-treated with Bucladesine] results in increased expression of PPARG protein CTD PMID:19698295 Butylbenzyl phthalate multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:24155963 more ... Butylbenzyl phthalate increases expression EXP 6480464 butylbenzyl phthalate results in increased expression of PPARG mRNA CTD PMID:27923775 , PMID:34520170 Butylbenzyl phthalate increases activity ISO RGD:69168 6480464 butylbenzyl phthalate results in increased activity of PPARG protein CTD PMID:26172262 Butylbenzyl phthalate affects binding ISO RGD:69168 6480464 butylbenzyl phthalate binds to PPARG protein CTD PMID:23843199 , PMID:32407875 Butylbenzyl phthalate multiple interactions ISO RGD:69168 6480464 butylbenzyl phthalate binds to and results in increased activity of PPARG protein, butylbenzyl phthalate inhibits the reaction [GW 1929 binds to PPARG protein] CTD PMID:24155963 more ... Butylparaben increases activity EXP 6480464 butylparaben results in increased activity of PPARG protein CTD PMID:28527915 Butylparaben multiple interactions EXP 6480464 2 more ... CTD PMID:22956630 more ... Butylparaben increases expression ISO RGD:69168 6480464 butylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 Butylparaben increases expression EXP 6480464 butylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 more ... Butylparaben multiple interactions ISO RGD:69168 6480464 butylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 Butylparaben increases response to substance EXP 6480464 PPARG protein results in increased susceptibility to butylparaben CTD PMID:28527915 butyric acid increases expression ISO RGD:69168 6480464 Butyric Acid results in increased expression of PPARG mRNA, Butyric Acid results in increased expression of PPARG protein CTD PMID:10833422 butyric acid multiple interactions EXP 6480464 Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 butyric acid multiple interactions ISO RGD:69168 6480464 [Butyric Acid co-treated with Lipopolysaccharides] results in increased expression of PPARG mRNA CTD PMID:29751049 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of PPARG protein CTD PMID:21848503 cadmium atom multiple interactions ISO RGD:69168 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPARG mRNA CTD PMID:35301059 cadmium atom increases expression ISO RGD:3371 6480464 Cadmium results in increased expression of PPARG mRNA CTD PMID:25388156 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PPARG mRNA, Cadmium Chloride results in decreased expression of PPARG protein CTD PMID:23921151 , PMID:31152847 cadmium dichloride multiple interactions ISO RGD:69168 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPARG mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO RGD:3371 6480464 Cadmium Chloride results in increased expression of PPARG protein CTD PMID:28283887 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PPARG mRNA CTD PMID:26352046 cadmium dichloride decreases expression ISO RGD:3371 6480464 Cadmium Chloride results in decreased expression of PPARG mRNA CTD PMID:25993096 cadmium dichloride affects activity ISO RGD:69168 6480464 Cadmium Chloride affects the activity of PPARG protein CTD PMID:25596134 cadmium dichloride multiple interactions ISO RGD:3371 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 , PMID:28283887 cadmium dichloride multiple interactions EXP 6480464 [MT1 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of PPARG mRNA, [MT2 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of PPARG mRNA CTD PMID:23921151 cadmium sulfate multiple interactions EXP 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of PPARG mRNA] CTD PMID:16221973 caffeine decreases expression ISO RGD:3371 6480464 Caffeine results in decreased expression of PPARG mRNA CTD PMID:23727198 caffeine decreases phosphorylation ISO RGD:69168 6480464 Caffeine results in decreased phosphorylation of PPARG protein CTD PMID:35688186 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of PPARG mRNA CTD PMID:23727198 calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of PPARG mRNA, Calcitriol results in decreased expression of PPARG protein CTD PMID:15036392 more ... calcitriol multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:29953732 cannabidiol increases expression ISO RGD:69168 6480464 Cannabidiol results in increased expression of PPARG mRNA CTD PMID:23220503 cannabidiol affects binding ISO RGD:69168 6480464 Cannabidiol analog binds to PPARG protein CTD PMID:30033591 cannabidiol increases activity EXP 6480464 Cannabidiol analog results in increased activity of PPARG protein CTD PMID:30033591 cannabidiol increases expression EXP 6480464 Cannabidiol analog results in increased expression of PPARG mRNA alternative form CTD PMID:30382123 cannabidiol decreases expression ISO RGD:69168 6480464 Cannabidiol results in decreased expression of PPARG protein CTD PMID:28853159 cannabidiol multiple interactions EXP 6480464 [lipopolysaccharide more ... CTD PMID:30033591 more ... cannabidiol affects binding EXP 6480464 Cannabidiol binds to PPARG protein CTD PMID:19285060 cannabidiol increases expression ISO RGD:3371 6480464 Cannabidiol results in increased expression of PPARG mRNA CTD PMID:19285060 cannabidiol multiple interactions ISO RGD:69168 6480464 Cannabidiol analog binds to and results in increased activity of PPARG protein more ... CTD PMID:23220503 more ... cannabidiolic acid decreases expression ISO RGD:69168 6480464 cannabidiolic acid results in decreased expression of PPARG protein CTD PMID:28853159 cannabidiolic acid multiple interactions EXP 6480464 cannabidiolic acid binds to and results in increased activity of PPARG protein, cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] CTD PMID:30611848 cannabidiolic acid multiple interactions ISO RGD:69168 6480464 cannabidiolic acid binds to and results in increased activity of PPARG protein CTD PMID:30611848 cannabidiolic acid increases expression EXP 6480464 cannabidiolic acid results in increased expression of PPARG mRNA CTD PMID:30611848 cannabidiolic acid increases expression ISO RGD:69168 6480464 cannabidiolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 cannabigerol increases expression ISO RGD:69168 6480464 cannabigerol results in increased expression of PPARG mRNA CTD PMID:28853159 cannabigerol multiple interactions ISO RGD:69168 6480464 cannabigerol binds to and results in increased activity of PPARG protein CTD PMID:30611848 cannabigerol multiple interactions EXP 6480464 cannabigerol binds to and results in increased activity of PPARG protein, cannabigerol promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] CTD PMID:30611848 cannabigerol decreases expression ISO RGD:69168 6480464 cannabigerol results in decreased expression of PPARG protein CTD PMID:28853159 cannabigerolic acid increases expression ISO RGD:69168 6480464 cannabigerolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 cannabigerolic acid multiple interactions ISO RGD:69168 6480464 cannabigerolic acid binds to and results in increased activity of PPARG protein CTD PMID:30611848 cannabigerolic acid multiple interactions EXP 6480464 cannabigerolic acid binds to and results in increased activity of PPARG protein, cannabigerolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] CTD PMID:30611848 cannabigerolic acid increases expression EXP 6480464 cannabigerolic acid results in increased expression of PPARG mRNA CTD PMID:30611848 cannabigerolic acid decreases expression ISO RGD:69168 6480464 cannabigerolic acid results in decreased expression of PPARG protein CTD PMID:28853159 capsaicin multiple interactions ISO RGD:3371 6480464 Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:20359164 capsaicin increases activity ISO RGD:69168 6480464 Capsaicin results in increased activity of PPARG protein CTD PMID:15383218 capsaicin decreases expression EXP 6480464 Capsaicin results in decreased expression of PPARG protein CTD PMID:17295509 capsaicin decreases expression ISO RGD:69168 6480464 Capsaicin results in decreased expression of PPARG mRNA CTD PMID:18769453 capsaicin multiple interactions ISO RGD:69168 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Capsaicin results in increased activity of PPARG protein] CTD PMID:15383218 carbamazepine affects expression ISO RGD:69168 6480464 Carbamazepine affects the expression of PPARG mRNA CTD PMID:24752500 carbon monoxide multiple interactions EXP 6480464 [Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein more ... CTD PMID:22046279 carbon nanotube multiple interactions ISO RGD:69168 6480464 PPARG protein affects the reaction [Nanotubes, Carbon results in increased expression of PLIN2 protein] CTD PMID:32649966 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 , PMID:25926378 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:69168 6480464 Nanotubes more ... CTD PMID:23634900 , PMID:32649966 carnosic acid increases activity ISO RGD:69168 6480464 salvin results in increased activity of PPARG protein CTD PMID:20696231 carotenoid decreases expression EXP 6480464 Carotenoids results in decreased expression of PPARG mRNA CTD PMID:11237167 casticin increases expression ISO RGD:69168 6480464 casticin results in increased expression of PPARG mRNA CTD PMID:27862857 celastrol affects expression EXP 6480464 celastrol affects the expression of PPARG mRNA, celastrol affects the expression of PPARG protein CTD PMID:27085773 celecoxib multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Celecoxib affects the localization of PPARG protein] more ... CTD PMID:19522023 , PMID:23943857 celecoxib multiple interactions EXP 6480464 [Celecoxib co-treated with docetaxel] results in increased expression of PPARG protein CTD PMID:16052515 celecoxib multiple interactions ISO RGD:3371 6480464 Celecoxib inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:19247274 celecoxib increases expression ISO RGD:69168 6480464 Celecoxib results in increased expression of PPARG mRNA, Celecoxib results in increased expression of PPARG protein CTD PMID:23943857 celecoxib affects localization ISO RGD:69168 6480464 Celecoxib affects the localization of PPARG protein CTD PMID:23943857 cerulenin decreases expression EXP 6480464 Cerulenin results in decreased expression of PPARG mRNA CTD PMID:15707987 ceruletide multiple interactions EXP 6480464 PPARG affects the reaction [Ceruletide results in increased expression of CCL2 mRNA], PPARG affects the reaction [Ceruletide results in increased expression of CXCL1 mRNA] CTD PMID:17463185 chalcone increases expression EXP 6480464 Chalcone analog results in increased expression of PPARG mRNA CTD PMID:28528971 chenodeoxycholic acid increases expression ISO RGD:69168 6480464 Chenodeoxycholic Acid results in increased expression of PPARG mRNA CTD PMID:27174168 chenodeoxycholic acid multiple interactions EXP 6480464 Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of PPARG mRNA], Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of PPARG protein] CTD PMID:35780845 chenodeoxycholic acid increases expression ISO RGD:3371 6480464 Chenodeoxycholic Acid results in increased expression of PPARG mRNA CTD PMID:15980055 CHIR 99021 multiple interactions ISO RGD:69168 6480464 [Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of PPARG mRNA CTD PMID:35267148 chloroacetaldehyde affects activity ISO RGD:69168 6480464 chloroacetaldehyde affects the activity of PPARG protein CTD PMID:25596134 Chlorobenzilate multiple interactions EXP 6480464 chlorobenzilate binds to and results in increased activity of PPARG protein CTD PMID:33049310 Chlorobenzilate multiple interactions ISO RGD:69168 6480464 chlorobenzilate binds to and results in increased activity of PPARG protein CTD PMID:33049310 chlorogenic acid increases expression EXP 6480464 Chlorogenic Acid results in increased expression of PPARG mRNA CTD PMID:21870829 chlorogenic acid decreases expression ISO RGD:69168 6480464 Chlorogenic Acid results in decreased expression of PPARG mRNA CTD PMID:20706672 chlorothalonil multiple interactions EXP 6480464 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PPARG mRNA CTD PMID:33246813 chlorothalonil decreases expression EXP 6480464 tetrachloroisophthalonitrile results in decreased expression of PPARG mRNA CTD PMID:33246813 chlorpromazine affects activity ISO RGD:3371 6480464 Chlorpromazine affects the activity of PPARG protein CTD PMID:25596134 chlorpyrifos increases expression ISO RGD:3371 6480464 Chlorpyrifos results in increased expression of PPARG mRNA CTD PMID:33994353 chlorpyrifos multiple interactions EXP 6480464 [Chlorpyrifos co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein, Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] CTD PMID:32017950 chlorpyrifos multiple interactions ISO RGD:69168 6480464 rosiglitazone inhibits the reaction [Chlorpyrifos results in decreased expression of PPARG protein] CTD PMID:24793810 chlorpyrifos decreases expression ISO RGD:69168 6480464 Chlorpyrifos results in decreased expression of PPARG mRNA, Chlorpyrifos results in decreased expression of PPARG protein CTD PMID:24793810 , PMID:31509763 chlorpyrifos-methyl multiple interactions ISO RGD:69168 6480464 chlorpyrifos-methyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 chlorpyrifos-methyl multiple interactions EXP 6480464 chlorpyrifos-methyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 cholesterol multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in decreased abundance of Cholesterol] more ... CTD PMID:12044893 more ... cholesterol multiple interactions EXP 6480464 [Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA more ... CTD PMID:18302760 more ... choline multiple interactions EXP 6480464 3 more ... CTD PMID:18991162 , PMID:28973532 chrysin multiple interactions EXP 6480464 chrysin binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 , PMID:33049310 chrysin multiple interactions ISO RGD:69168 6480464 chrysin binds to and results in increased activity of PPARG protein CTD PMID:33049310 cidofovir anhydrous affects activity ISO RGD:69168 6480464 Cidofovir affects the activity of PPARG protein CTD PMID:25596134 ciglitazone multiple interactions EXP 6480464 [ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA more ... CTD PMID:12847270 more ... ciglitazone affects localization ISO RGD:3371 6480464 ciglitazone affects the localization of PPARG protein CTD PMID:20578043 ciglitazone increases expression EXP 6480464 ciglitazone results in increased expression of PPARG protein CTD PMID:19698295 ciglitazone decreases response to substance ISO RGD:69168 6480464 PPARG protein mutant form results in decreased susceptibility to ciglitazone CTD PMID:19922793 ciglitazone affects binding ISO RGD:69168 6480464 ciglitazone binds to PPARG protein CTD PMID:12839938 , PMID:21511917 ciglitazone increases localization ISO RGD:69168 6480464 ciglitazone results in increased localization of PPARG protein CTD PMID:12517972 ciglitazone increases activity ISO RGD:69168 6480464 ciglitazone results in increased activity of PPARG protein CTD PMID:12517972 more ... ciglitazone increases activity EXP 6480464 ciglitazone results in increased activity of PPARG protein CTD PMID:11683414 , PMID:16023420 ciglitazone multiple interactions ISO RGD:3371 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:16820301 , PMID:18063688 ciglitazone increases expression ISO RGD:69168 6480464 ciglitazone results in increased expression of PPARG mRNA, ciglitazone results in increased expression of PPARG protein CTD PMID:11840453 more ... ciglitazone multiple interactions ISO RGD:69168 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of ABHD3 mRNA more ... CTD PMID:11030710 more ... cilnidipine decreases activity ISO RGD:69168 6480464 cilnidipine results in decreased activity of PPARG protein CTD PMID:25257666 cilostazol increases activity ISO RGD:69168 6480464 cilostazol results in increased activity of PPARG protein CTD PMID:21660147 cilostazol multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [cilostazol results in increased activity of PPARG protein] more ... CTD PMID:21660147 cis-caffeic acid increases expression EXP 6480464 caffeic acid results in increased expression of PPARG mRNA CTD PMID:21870829 cisplatin multiple interactions ISO RGD:69168 6480464 [rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to Cisplatin more ... CTD PMID:21781307 , PMID:27417252 cisplatin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Cisplatin results in decreased expression of PPARG protein] CTD PMID:34428482 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of PPARG protein CTD PMID:34428482 cisplatin affects activity ISO RGD:69168 6480464 Cisplatin affects the activity of PPARG protein CTD PMID:25596134 cisplatin decreases expression ISO RGD:69168 6480464 Cisplatin results in decreased expression of PPARG protein CTD PMID:27417252 cisplatin affects expression ISO RGD:69168 6480464 Cisplatin affects the expression of PPARG mRNA CTD PMID:23300844 cisplatin decreases expression ISO RGD:3371 6480464 Cisplatin results in decreased expression of PPARG mRNA, Cisplatin results in decreased expression of PPARG protein CTD PMID:22989705 more ... cisplatin multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:22989705 more ... Citreoviridin multiple interactions ISO RGD:3371 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein], Thiamine inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:31419397 Citreoviridin decreases activity ISO RGD:3371 6480464 citreoviridin results in decreased activity of PPARG protein CTD PMID:31419397 citronellol increases activity ISO RGD:69168 6480464 citronellol results in increased activity of PPARG protein CTD PMID:21597168 citronellol multiple interactions ISO RGD:69168 6480464 citronellol inhibits the reaction [PPARG protein results in increased expression of PTGS2 mRNA] CTD PMID:21597168 Clinofibrate affects binding ISO RGD:69168 6480464 clinofibrate binds to PPARG protein CTD PMID:11779144 clodronic acid affects activity ISO RGD:69168 6480464 Clodronic Acid affects the activity of PPARG protein CTD PMID:25596134 clofazimine increases expression ISO RGD:3371 6480464 Clofazimine results in increased expression of PPARG mRNA, Clofazimine results in increased expression of PPARG protein CTD PMID:31393584 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with PPARG] results in increased expression of FABP4 mRNA more ... CTD PMID:9543393 clofibrate increases expression ISO RGD:3371 6480464 Clofibrate results in increased expression of PPARG mRNA, Clofibrate results in increased expression of PPARG protein CTD PMID:12604186 , PMID:12699904 clofibrate multiple interactions ISO RGD:3371 6480464 PPARG protein promotes the reaction [Clofibrate results in decreased expression of ALDH3A1 mRNA] CTD PMID:12604186 clofibrate affects response to substance ISO RGD:3371 6480464 PPARG protein affects the susceptibility to Clofibrate CTD PMID:12604186 clofibrate multiple interactions ISO RGD:69168 6480464 Clofibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein] CTD PMID:11779144 clofibrate increases response to substance ISO RGD:3371 6480464 PPARG results in increased susceptibility to Clofibrate CTD PMID:12699904 clofibric acid affects binding ISO RGD:69168 6480464 Clofibric Acid binds to PPARG protein CTD PMID:11779144 , PMID:35752307 clofibric acid affects binding ISO RGD:3371 6480464 Clofibric Acid binds to PPARG protein CTD PMID:35752307 Clofop increases activity ISO RGD:69168 6480464 fenofibric acid results in increased activity of PPARG protein CTD PMID:15273253 Clofop multiple interactions ISO RGD:69168 6480464 fenofibric acid results in increased activity of [PPARG protein alternative form binds to RXRA protein] CTD PMID:11779144 Clofop affects binding ISO RGD:69168 6480464 fenofibric acid binds to PPARG protein CTD PMID:11779144 clozapine multiple interactions EXP 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA], Berberine inhibits the reaction [Clozapine results in increased expression of PPARG protein] CTD PMID:20564506 clozapine increases expression EXP 6480464 Clozapine results in increased expression of PPARG mRNA, Clozapine results in increased expression of PPARG protein CTD PMID:20564506 cobalt dichloride decreases expression ISO RGD:69168 6480464 cobaltous chloride results in decreased expression of PPARG mRNA CTD PMID:15708366 cobalt dichloride multiple interactions EXP 6480464 2 more ... CTD PMID:32408695 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PPARG mRNA CTD PMID:20594416 colforsin daropate hydrochloride decreases expression ISO RGD:69168 6480464 Colforsin results in decreased expression of PPARG mRNA CTD PMID:31278978 conjugated linoleic acid decreases activity ISO RGD:69168 6480464 Linoleic Acids, Conjugated results in decreased activity of PPARG protein CTD PMID:18776171 conjugated linoleic acid increases expression EXP 6480464 Linoleic Acids, Conjugated results in increased expression of PPARG mRNA CTD PMID:17322064 conjugated linoleic acid increases expression ISO RGD:69168 6480464 Linoleic Acids more ... CTD PMID:15961301 conjugated linoleic acid multiple interactions ISO RGD:69168 6480464 Linoleic Acids more ... CTD PMID:18776171 conjugated linoleic acid decreases expression ISO RGD:69168 6480464 Linoleic Acids, Conjugated results in decreased expression of PPARG protein CTD PMID:16933788 copper atom multiple interactions ISO RGD:69168 6480464 [Chelating Agents binds to Copper] which affects the expression of PPARG mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:69168 6480464 [Chelating Agents binds to Copper] which affects the expression of PPARG mRNA CTD PMID:30911355 corilagin multiple interactions ISO RGD:3371 6480464 corilagin inhibits the reaction [Doxorubicin results in increased expression of PPARG protein] CTD PMID:34605098 corticosterone multiple interactions EXP 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA, Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 cortisol multiple interactions ISO RGD:69168 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA more ... CTD PMID:33476690 cortisone multiple interactions EXP 6480464 2-(3-benzoyl)-4-hydroxy-1 more ... CTD PMID:21315688 cortisone increases expression EXP 6480464 Cortisone results in increased expression of PPARG mRNA CTD PMID:21315688 coumaphos multiple interactions EXP 6480464 Coumaphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 coumaphos multiple interactions ISO RGD:69168 6480464 Coumaphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 crocidolite asbestos increases expression ISO RGD:69168 6480464 Asbestos more ... CTD PMID:23634900 cucurbitacin B multiple interactions EXP 6480464 STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of PPARG mRNA] CTD PMID:24316209 cucurbitacin B decreases expression EXP 6480464 cucurbitacin B results in decreased expression of PPARG mRNA CTD PMID:24316209 cucurbitacin I decreases expression EXP 6480464 cucurbitacin I results in decreased expression of PPARG mRNA CTD PMID:24316209 curcumin affects binding ISO RGD:69168 6480464 Curcumin binds to PPARG protein CTD PMID:15713005 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of PPARG mRNA CTD PMID:23603106 curcumin increases expression ISO RGD:3371 6480464 Curcumin results in increased expression of PPARG mRNA, Curcumin results in increased expression of PPARG protein CTD PMID:16959952 more ... curcumin increases activity ISO RGD:3371 6480464 Curcumin results in increased activity of PPARG protein CTD PMID:18332871 curcumin decreases expression ISO RGD:3371 6480464 Curcumin results in decreased expression of PPARG protein CTD PMID:19225048 curcumin affects localization ISO RGD:3371 6480464 Curcumin affects the localization of PPARG protein CTD PMID:17531121 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] more ... CTD PMID:19297423 more ... curcumin multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:16782535 more ... curcumin multiple interactions ISO RGD:69168 6480464 PPARG protein promotes the reaction [Curcumin results in decreased expression of CCN2 mRNA] CTD PMID:17965732 curcumin increases activity ISO RGD:69168 6480464 Curcumin results in increased activity of PPARG protein CTD PMID:15486348 curcumin decreases expression ISO RGD:69168 6480464 Curcumin results in decreased expression of PPARG protein modified form CTD PMID:15486348 cyanamide multiple interactions ISO RGD:69168 6480464 Cyanamide inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] CTD PMID:17030193 cyanocob(III)alamin multiple interactions ISO RGD:3371 6480464 [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA], Vitamin B 12 inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:23935743 cyclophosphamide increases expression ISO RGD:3371 6480464 Cyclophosphamide results in increased expression of PPARG mRNA CTD PMID:27281708 cyclophosphamide multiple interactions ISO RGD:3371 6480464 Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of PPARG mRNA] CTD PMID:25446862 cyclophosphamide decreases expression ISO RGD:3371 6480464 Cyclophosphamide results in decreased expression of PPARG mRNA CTD PMID:25446862 cyclosporin A multiple interactions ISO RGD:69168 6480464 [Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein CTD PMID:17016853 cyclosporin A affects activity ISO RGD:3371 6480464 Cyclosporine affects the activity of PPARG protein CTD PMID:25596134 cyclosporin A affects activity ISO RGD:69168 6480464 Cyclosporine affects the activity of PPARG protein CTD PMID:25596134 cyclosporin A decreases expression ISO RGD:3371 6480464 Cyclosporine results in decreased expression of PPARG mRNA, Cyclosporine results in decreased expression of PPARG protein CTD PMID:17461532 cyclosporin A multiple interactions ISO RGD:3371 6480464 Cyclosporine inhibits the reaction [rosiglitazone results in increased expression of PPARG protein] more ... CTD PMID:17461532 cyclosporin A increases expression ISO RGD:69168 6480464 Cyclosporine results in increased expression of PPARG mRNA CTD PMID:20106945 cyfluthrin multiple interactions EXP 6480464 cyfluthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 cyfluthrin multiple interactions ISO RGD:69168 6480464 cyfluthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 cyhalothrin increases expression ISO RGD:3371 6480464 cyhalothrin results in increased expression of PPARG mRNA CTD PMID:27348886 cypermethrin multiple interactions ISO RGD:69168 6480464 cypermethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 cypermethrin multiple interactions EXP 6480464 cypermethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 cyproterone acetate multiple interactions ISO RGD:69168 6480464 Cyproterone Acetate binds to and results in increased activity of PPARG protein CTD PMID:33049310 cyproterone acetate multiple interactions EXP 6480464 Cyproterone Acetate binds to and results in increased activity of PPARG protein CTD PMID:33049310 cytarabine multiple interactions EXP 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of PPARG mRNA] CTD PMID:23264188 cytarabine increases expression EXP 6480464 Cytarabine results in increased expression of PPARG mRNA CTD PMID:23264188 D-glucose multiple interactions ISO RGD:3371 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... D-glucose decreases expression ISO RGD:69168 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 D-glucose multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 more ... D-glucose decreases expression ISO RGD:3371 6480464 Glucose results in decreased expression of PPARG mRNA, Glucose results in decreased expression of PPARG protein CTD PMID:19609456 , PMID:31063766 daunorubicin decreases activity ISO RGD:69168 6480464 Daunorubicin results in decreased activity of PPARG protein CTD PMID:25257666 daunorubicin increases expression ISO RGD:3371 6480464 Daunorubicin results in increased expression of PPARG protein CTD PMID:20888384 daunorubicin multiple interactions ISO RGD:3371 6480464 telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] CTD PMID:20888384 DDD multiple interactions EXP 6480464 Dichlorodiphenyldichloroethane binds to and results in increased activity of PPARG protein CTD PMID:33049310 DDE multiple interactions ISO RGD:69168 6480464 [Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA CTD PMID:26200599 DDT increases expression ISO RGD:69168 6480464 DDT results in increased expression of PPARG mRNA CTD PMID:25014179 DDT multiple interactions ISO RGD:69168 6480464 DDT binds to and results in increased activity of PPARG protein CTD PMID:33049310 DDT multiple interactions EXP 6480464 DDT binds to and results in increased activity of PPARG protein, DDT results in increased activity of and results in increased localization of PPARG protein CTD PMID:11911853 , PMID:33049310 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of PPARG protein CTD PMID:30743236 decanoic acid increases activity ISO RGD:69168 6480464 decanoic acid results in increased activity of PPARG protein CTD PMID:24998974 decanoic acid affects binding ISO RGD:69168 6480464 decanoic acid binds to PPARG protein CTD PMID:24998974 Delta(9)-tetrahydrocannabinolic acid increases expression ISO RGD:69168 6480464 delta(9)-tetrahydrocannabinolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 Delta(9)-tetrahydrocannabinolic acid decreases expression ISO RGD:69168 6480464 delta(9)-tetrahydrocannabinolic acid results in decreased expression of PPARG protein CTD PMID:28853159 Delta(9)-tetrahydrocannabinolic acid multiple interactions ISO RGD:69168 6480464 delta(9)-tetrahydrocannabinolic acid inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA] CTD PMID:28853159 delta-tocopherol multiple interactions ISO RGD:3371 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 demethoxycurcumin affects binding ISO RGD:69168 6480464 demethoxycurcumin binds to PPARG protein CTD PMID:15713005 deoxycholic acid decreases expression EXP 6480464 Deoxycholic Acid results in decreased expression of PPARG mRNA CTD PMID:23911798 deoxynivalenol multiple interactions ISO RGD:69168 6480464 15-deoxy-delta(12 more ... CTD PMID:18485432 deoxynivalenol decreases activity ISO RGD:69168 6480464 deoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 deoxynivalenol increases expression ISO RGD:69168 6480464 deoxynivalenol results in increased expression of PPARG mRNA CTD PMID:18485432 dexamethasone multiple interactions EXP 6480464 (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein] more ... CTD PMID:11101056 more ... dexamethasone increases expression ISO RGD:69168 6480464 Dexamethasone results in increased expression of PPARG mRNA, Dexamethasone results in increased expression of PPARG protein CTD PMID:16569937 more ... dexamethasone increases expression ISO RGD:3371 6480464 Dexamethasone results in increased expression of PPARG mRNA, Dexamethasone results in increased expression of PPARG protein CTD PMID:14568882 , PMID:19118567 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of PPARG mRNA more ... CTD PMID:16814746 more ... dexamethasone multiple interactions ISO RGD:3371 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA more ... CTD PMID:16782535 , PMID:21350315 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of PPARG mRNA CTD PMID:16889531 dexamethasone multiple interactions ISO RGD:69168 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:17290005 more ... dextran sulfate increases expression EXP 6480464 Dextran Sulfate results in increased expression of PPARG protein CTD PMID:23261717 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARG mRNA more ... CTD PMID:29950665 , PMID:33130971 dextran sulfate affects localization EXP 6480464 Dextran Sulfate affects the localization of PPARG protein CTD PMID:33130971 Di-n-decyl phthalate affects binding ISO RGD:69168 6480464 didecyl phthalate binds to PPARG protein CTD PMID:23843199 Di-n-hexyl phthalate affects binding ISO RGD:69168 6480464 di-n-hexyl phthalate binds to PPARG protein CTD PMID:23843199 diallyl trisulfide decreases expression EXP 6480464 diallyl trisulfide results in decreased expression of PPARG mRNA, diallyl trisulfide results in decreased expression of PPARG protein CTD PMID:22137902 diallyl trisulfide multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide results in decreased expression of and results in decreased activity of PPARG protein] more ... CTD PMID:22137902 diallyl trisulfide decreases activity EXP 6480464 diallyl trisulfide results in decreased activity of PPARG protein CTD PMID:22137902 diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein] more ... CTD PMID:15916724 , PMID:30362509 diarsenic trioxide decreases expression ISO RGD:3371 6480464 Arsenic Trioxide results in decreased expression of PPARG mRNA CTD PMID:31258454 diarsenic trioxide decreases response to substance ISO RGD:69168 6480464 PPARG protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:15916724 , PMID:30362509 diarsenic trioxide decreases expression ISO RGD:69168 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:30362509 diarsenic trioxide multiple interactions ISO RGD:69168 6480464 [Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide more ... CTD PMID:22684020 more ... diarsenic trioxide increases expression ISO RGD:69168 6480464 Arsenic Trioxide results in increased expression of PPARG mRNA, Arsenic Trioxide results in increased expression of PPARG protein CTD PMID:22684020 diazinon increases activity ISO RGD:69168 6480464 Diazinon results in increased activity of PPARG protein CTD PMID:28728110 dibutyl phthalate multiple interactions ISO RGD:69168 6480464 Dibutyl Phthalate binds to and results in increased activity of PPARG protein CTD PMID:24155963 more ... dibutyl phthalate increases expression ISO RGD:69168 6480464 Dibutyl Phthalate results in increased expression of PPARG protein CTD PMID:29061543 dibutyl phthalate increases activity ISO RGD:69168 6480464 Dibutyl Phthalate results in increased activity of PPARG protein CTD PMID:26172262 dibutyl phthalate multiple interactions EXP 6480464 Dibutyl Phthalate binds to and results in increased activity of PPARG protein CTD PMID:33049310 dibutyl phthalate affects binding ISO RGD:69168 6480464 Dibutyl Phthalate binds to PPARG protein CTD PMID:23843199 dibutylstannane multiple interactions ISO RGD:69168 6480464 T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of PPARG mRNA] CTD PMID:29787037 dibutylstannane increases expression ISO RGD:69168 6480464 di-n-butyltin results in increased expression of PPARG mRNA CTD PMID:29787037 dibutylstannane increases expression EXP 6480464 di-n-butyltin results in increased expression of PPARG mRNA CTD PMID:29787037 dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of PPARG mRNA CTD PMID:28962523 diclofenac affects expression ISO RGD:69168 6480464 Diclofenac affects the expression of PPARG mRNA CTD PMID:24752500 diclofenac multiple interactions ISO RGD:69168 6480464 Diclofenac inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30138673 diclofenac increases activity ISO RGD:69168 6480464 Diclofenac results in increased activity of PPARG protein CTD PMID:12065695 more ... diethyl phthalate affects binding ISO RGD:69168 6480464 diethyl phthalate binds to PPARG protein CTD PMID:23843199 diethylstilbestrol multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of PPARG protein] more ... CTD PMID:22710028 , PMID:26944108 diethylstilbestrol increases activity EXP 6480464 Diethylstilbestrol results in increased activity of PPARG protein CTD PMID:22710028 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of PPARG mRNA, Diethylstilbestrol results in increased expression of PPARG protein CTD PMID:22710028 diheptyl phthalate affects binding ISO RGD:69168 6480464 diheptyl phthalate binds to PPARG protein CTD PMID:23843199 diisobutyl phthalate multiple interactions ISO RGD:69168 6480464 diisobutyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:24155963 , PMID:27633901 diisobutyl phthalate increases expression ISO RGD:69168 6480464 diisobutyl phthalate results in increased expression of PPARG protein CTD PMID:29061543 diisobutyl phthalate increases activity ISO RGD:69168 6480464 diisobutyl phthalate results in increased activity of PPARG protein CTD PMID:26172262 Diisodecyl phthalate affects binding ISO RGD:69168 6480464 diisodecyl phthalate binds to PPARG protein CTD PMID:23843199 Diisodecyl phthalate multiple interactions ISO RGD:69168 6480464 diisodecyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:29410257 Diisodecyl phthalate increases expression EXP 6480464 diisodecyl phthalate results in increased expression of PPARG mRNA CTD PMID:29410257 diisononyl phthalate affects binding ISO RGD:69168 6480464 diisononyl phthalate binds to PPARG protein CTD PMID:23843199 diisononyl phthalate increases expression EXP 6480464 diisononyl phthalate results in increased expression of PPARG mRNA CTD PMID:29410257 diisononyl phthalate multiple interactions ISO RGD:69168 6480464 diisononyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:29410257 diisononyl phthalate affects activity ISO RGD:69168 6480464 diisononyl phthalate affects the activity of PPARG protein CTD PMID:26172262 dimethomorph multiple interactions ISO RGD:69168 6480464 dimethomorph binds to and results in increased activity of PPARG protein CTD PMID:33049310 dimethomorph multiple interactions EXP 6480464 dimethomorph binds to and results in increased activity of PPARG protein CTD PMID:33049310 Dimethyl phthalate affects binding ISO RGD:69168 6480464 dimethyl phthalate binds to PPARG protein CTD PMID:23843199 dimethyl sulfoxide decreases expression ISO RGD:69168 6480464 Dimethyl Sulfoxide results in decreased expression of PPARG mRNA CTD PMID:21878375 dimethylarsinic acid decreases expression ISO RGD:69168 6480464 Cacodylic Acid results in decreased expression of PPARG mRNA CTD PMID:23221991 dimethylarsinic acid multiple interactions ISO RGD:69168 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA CTD PMID:28793237 dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of PPARG mRNA CTD PMID:23221991 diniconazole multiple interactions EXP 6480464 diniconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 diniconazole multiple interactions ISO RGD:69168 6480464 diniconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 diosgenin increases expression EXP 6480464 Diosgenin results in increased expression of PPARG protein CTD PMID:24001619 diosgenin increases expression ISO RGD:69168 6480464 Diosgenin results in increased expression of PPARG mRNA CTD PMID:32347045 diosgenin decreases response to substance EXP 6480464 PPARG protein results in decreased susceptibility to Diosgenin CTD PMID:26408789 diosgenin multiple interactions EXP 6480464 [Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]] which results in decreased activity of PPARG protein more ... CTD PMID:26408789 diosgenin decreases expression EXP 6480464 Diosgenin results in decreased expression of PPARG mRNA CTD PMID:26408789 dioxygen decreases expression ISO RGD:69168 6480464 Oxygen deficiency results in decreased expression of PPARG protein CTD PMID:19520921 dioxygen multiple interactions ISO RGD:69168 6480464 [Oxygen deficiency co-treated with Oxygen] results in decreased expression of PPARG mRNA more ... CTD PMID:34995009 dioxygen increases expression ISO RGD:69168 6480464 Oxygen deficiency results in increased expression of PPARG mRNA CTD PMID:26516004 dioxygen affects activity ISO RGD:69168 6480464 Oxygen deficiency affects the activity of PPARG protein CTD PMID:25596134 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of PPARG protein, Oxygen results in increased expression of PPARG mRNA CTD PMID:21113404 , PMID:22535284 dioxygen decreases expression ISO RGD:3371 6480464 Oxygen results in decreased expression of PPARG mRNA, Oxygen results in decreased expression of PPARG protein CTD PMID:16617452 dioxygen multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:16617452 more ... dioxygen multiple interactions EXP 6480464 [Dexamethasone co-treated with Oxygen deficiency] results in increased expression of PPARG mRNA alternative form more ... CTD PMID:16814746 more ... dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of PPARG mRNA, Oxygen deficiency results in decreased expression of PPARG protein CTD PMID:21531777 dipentyl phthalate affects binding ISO RGD:69168 6480464 di-n-pentyl phthalate binds to PPARG protein CTD PMID:23843199 dipentyl phthalate multiple interactions EXP 6480464 di-n-pentyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:33049310 dipentyl phthalate multiple interactions ISO RGD:69168 6480464 di-n-pentyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:33049310 Diphenolic acid multiple interactions ISO RGD:69168 6480464 diphenolic acid binds to and results in decreased activity of PPARG protein CTD PMID:33049310 dipropyl phthalate affects binding ISO RGD:69168 6480464 di-n-propylphthalate binds to PPARG protein CTD PMID:23843199 disodium selenite multiple interactions ISO RGD:3371 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA], Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:21705299 , PMID:31419397 disodium selenite increases activity ISO RGD:3371 6480464 Sodium Selenite results in increased activity of PPARG protein CTD PMID:31419397 disodium selenite increases expression ISO RGD:3371 6480464 Sodium Selenite results in increased expression of PPARG protein CTD PMID:24140496 disulfiram multiple interactions EXP 6480464 Disulfiram binds to and results in increased activity of PPARG protein CTD PMID:33049310 disulfiram affects expression ISO RGD:69168 6480464 Disulfiram affects the expression of PPARG mRNA CTD PMID:32712770 disulfiram multiple interactions ISO RGD:69168 6480464 Disulfiram binds to and results in increased activity of PPARG protein CTD PMID:33049310 Dithiopyr multiple interactions ISO RGD:69168 6480464 dithiopyr binds to and results in increased activity of PPARG protein CTD PMID:33049310 Dithiopyr multiple interactions EXP 6480464 dithiopyr binds to and results in increased activity of PPARG protein CTD PMID:33049310 diuron increases expression ISO RGD:3371 6480464 Diuron results in increased expression of PPARG mRNA CTD PMID:21551480 diuron multiple interactions EXP 6480464 Diuron binds to and results in increased activity of PPARG protein CTD PMID:33049310 dodecylamine multiple interactions ISO RGD:69168 6480464 dodecylamine binds to and results in increased activity of PPARG protein CTD PMID:33049310 dodecylamine multiple interactions EXP 6480464 dodecylamine binds to and results in increased activity of PPARG protein CTD PMID:33049310 doramapimod increases expression EXP 6480464 doramapimod results in increased expression of PPARG mRNA CTD PMID:21328587 dorsomorphin multiple interactions ISO RGD:3371 6480464 dorsomorphin inhibits the reaction [25-hydroxyprotopanaxadiol results in increased phosphorylation of PPARG protein] CTD PMID:33676887 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]] CTD PMID:30446312 dorsomorphin multiple interactions ISO RGD:69168 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:24584901 , PMID:27188386 doxorubicin decreases activity ISO RGD:69168 6480464 Doxorubicin results in decreased activity of PPARG protein CTD PMID:25257666 doxorubicin increases expression ISO RGD:3371 6480464 Doxorubicin results in increased expression of PPARG protein CTD PMID:34605098 doxorubicin decreases expression ISO RGD:3371 6480464 Doxorubicin results in decreased expression of PPARG protein CTD PMID:30836069 doxorubicin multiple interactions ISO RGD:3371 6480464 caryophyllene inhibits the reaction [Doxorubicin results in decreased expression of PPARG protein] more ... CTD PMID:30836069 , PMID:34605098 doxorubicin decreases expression ISO RGD:69168 6480464 Doxorubicin results in decreased expression of PPARG mRNA, Doxorubicin results in decreased expression of PPARG protein CTD PMID:27417252 , PMID:29803840 doxorubicin multiple interactions ISO RGD:69168 6480464 [15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to Doxorubicin, [nimesulide co-treated with Doxorubicin] results in increased expression of PPARG CTD PMID:14567645 , PMID:23964924 efavirenz decreases expression ISO RGD:69168 6480464 efavirenz results in decreased expression of PPARG mRNA CTD PMID:21619898 elemental selenium multiple interactions EXP 6480464 PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide more ... CTD PMID:17439952 ellagic acid increases expression ISO RGD:69168 6480464 Ellagic Acid results in increased expression of PPARG protein CTD PMID:23811531 emodin increases expression ISO RGD:69168 6480464 Emodin results in increased expression of PPARG protein CTD PMID:25448808 emodin multiple interactions ISO RGD:69168 6480464 Emodin results in increased stability of and results in increased expression of PPARG mRNA CTD PMID:25448808 enalapril decreases expression ISO RGD:3371 6480464 Enalapril results in decreased expression of PPARG protein CTD PMID:19225048 enalapril multiple interactions ISO RGD:3371 6480464 Enalapril inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein] CTD PMID:30623541 endosulfan increases expression ISO RGD:3371 6480464 Endosulfan results in increased expression of PPARG mRNA CTD PMID:29391264 endrin decreases expression EXP 6480464 Endrin results in decreased expression of PPARG protein CTD PMID:10385688 enilconazole multiple interactions ISO RGD:69168 6480464 enilconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 enilconazole multiple interactions EXP 6480464 enilconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 epoxiconazole affects expression EXP 6480464 epoxiconazole affects the expression of PPARG mRNA CTD PMID:35436446 epoxomicin multiple interactions EXP 6480464 epoxomicin inhibits the reaction [resveratrol results in decreased expression of PPARG protein], epoxomicin inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein] CTD PMID:18555852 equilin multiple interactions EXP 6480464 Equilin binds to and results in decreased activity of PPARG protein CTD PMID:33049310 esculetin multiple interactions ISO RGD:3371 6480464 esculetin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein], esculetin inhibits the reaction [Streptozocin results in increased expression of PPARG protein] CTD PMID:21450970 esculetin multiple interactions EXP 6480464 esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA] CTD PMID:27769711 Ethalfluralin multiple interactions EXP 6480464 ethafluralin binds to and results in increased activity of PPARG protein CTD PMID:33049310 Ethalfluralin multiple interactions ISO RGD:69168 6480464 ethafluralin binds to and results in increased activity of PPARG protein CTD PMID:33049310 ethanol multiple interactions ISO RGD:69168 6480464 Cyanamide inhibits the reaction [Ethanol inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]] more ... CTD PMID:17030193 more ... ethanol decreases expression ISO RGD:69168 6480464 Ethanol results in decreased expression of PPARG mRNA, Ethanol results in decreased expression of PPARG protein CTD PMID:28062356 , PMID:34192554 ethanol decreases expression ISO RGD:3371 6480464 [Ethanol results in decreased expression of PPARG protein] which results in decreased expression of ADIPOQ protein more ... CTD PMID:24412557 ethanol increases expression ISO RGD:3371 6480464 Ethanol results in increased expression of PPARG mRNA CTD PMID:18793633 more ... ethanol increases expression EXP 6480464 Ethanol results in increased expression of PPARG mRNA, Ethanol results in increased expression of PPARG protein CTD PMID:18620774 more ... ethanol increases expression ISO RGD:69168 6480464 Ethanol results in increased expression of PPARG mRNA CTD PMID:24144995 ethanol affects expression EXP 6480464 Ethanol affects the expression of PPARG mRNA CTD PMID:19167417 ethanol multiple interactions EXP 6480464 [ADORA1 gene mutant form results in increased susceptibility to Ethanol] which results in increased expression of PPARG mRNA more ... CTD PMID:18755807 more ... ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PPARG mRNA, Ethanol results in decreased expression of PPARG protein CTD PMID:22173916 , PMID:34192554 ethanol multiple interactions ISO RGD:3371 6480464 [Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA more ... CTD PMID:15318101 more ... ethyl 3,4-dihydroxybenzoate multiple interactions EXP 6480464 ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA] CTD PMID:24338020 ethyl myristate multiple interactions ISO RGD:69168 6480464 ethyl myristate binds to and results in decreased activity of PPARG protein CTD PMID:27633901 ethylparaben increases expression EXP 6480464 ethyl-p-hydroxybenzoate results in increased expression of PPARG mRNA CTD PMID:22956630 eugenol multiple interactions ISO RGD:69168 6480464 Eugenol analog binds to and results in increased activity of PPARG protein CTD PMID:20064974 eugenol increases expression EXP 6480464 Eugenol results in increased expression of PPARG mRNA CTD PMID:21870829 eugenol multiple interactions EXP 6480464 2 more ... CTD PMID:20064974 Evodiamine decreases expression EXP 6480464 evodiamine results in decreased expression of PPARG CTD PMID:17884939 farnesol multiple interactions ISO RGD:69168 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of PPARG mRNA CTD PMID:30611723 farnesol increases expression ISO RGD:69168 6480464 Farnesol analog results in increased expression of PPARG mRNA CTD PMID:30611723 fenamiphos multiple interactions ISO RGD:69168 6480464 fenamiphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenamiphos multiple interactions EXP 6480464 fenamiphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenarimol multiple interactions EXP 6480464 fenarimol binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenarimol multiple interactions ISO RGD:69168 6480464 fenarimol binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenchone multiple interactions ISO RGD:69168 6480464 fenchone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 fenitrothion multiple interactions EXP 6480464 Fenitrothion binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenitrothion multiple interactions ISO RGD:69168 6480464 Fenitrothion binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenofibrate increases expression ISO RGD:69168 6480464 Fenofibrate results in increased expression of PPARG mRNA CTD PMID:19201410 , PMID:28034800 fenofibrate affects activity ISO RGD:3371 6480464 Fenofibrate affects the activity of PPARG protein CTD PMID:25596134 fenofibrate affects activity ISO RGD:69168 6480464 Fenofibrate affects the activity of PPARG protein CTD PMID:25596134 fenofibrate multiple interactions ISO RGD:69168 6480464 [Oleic Acid co-treated with Fenofibrate] results in increased expression of PPARG mRNA CTD PMID:24534255 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of PPARG mRNA CTD PMID:19201410 fenoprofen multiple interactions ISO RGD:69168 6480464 Fenoprofen binds to and results in increased activity of PPARG protein CTD PMID:9013583 fenthion increases expression ISO RGD:69168 6480464 Fenthion results in increased expression of PPARG mRNA CTD PMID:32473317 fenthion multiple interactions EXP 6480464 Fenthion binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenthion multiple interactions ISO RGD:69168 6480464 Fenthion binds to and results in increased activity of PPARG protein CTD PMID:33049310 fentin chloride multiple interactions ISO RGD:69168 6480464 diphenyltin chloride inhibits the reaction [triphenyltin chloride binds to PPARG protein] more ... CTD PMID:19497422 , PMID:33049310 fentin chloride increases activity ISO RGD:69168 6480464 triphenyltin chloride results in increased activity of PPARG protein CTD PMID:26172262 fentin chloride multiple interactions EXP 6480464 triphenyltin chloride binds to and results in increased activity of PPARG protein CTD PMID:33049310 fentin hydroxide increases expression ISO RGD:69168 6480464 triphenyltin hydroxide results in increased expression of PPARG mRNA CTD PMID:32473317 ferulic acid increases expression EXP 6480464 ferulic acid results in increased expression of PPARG mRNA CTD PMID:21870829 finasteride multiple interactions EXP 6480464 Finasteride binds to and results in increased activity of PPARG protein CTD PMID:33049310 fipronil increases expression EXP 6480464 fipronil results in increased expression of PPARG mRNA, fipronil results in increased expression of PPARG protein CTD PMID:27103584 flavanone increases expression ISO RGD:69168 6480464 flavanone results in increased expression of PPARG protein CTD PMID:22056764 flavonoids decreases expression ISO RGD:3371 6480464 Flavonoids results in decreased expression of PPARG mRNA CTD PMID:23238999 fluconazole increases expression ISO RGD:3371 6480464 Fluconazole results in increased expression of PPARG mRNA CTD PMID:20623750 fludioxonil multiple interactions EXP 6480464 fludioxonil binds to and results in increased activity of PPARG protein CTD PMID:33049310 fludioxonil multiple interactions ISO RGD:69168 6480464 fludioxonil binds to and results in increased activity of PPARG protein CTD PMID:33049310 flufenamic acid multiple interactions ISO RGD:69168 6480464 [Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein, Flufenamic Acid binds to and results in increased activity of PPARG protein CTD PMID:10866999 , PMID:9013583 flufenamic acid increases activity ISO RGD:69168 6480464 Flufenamic Acid results in increased activity of PPARG protein CTD PMID:10866999 Flumetralin multiple interactions EXP 6480464 flumetralin binds to and results in increased activity of PPARG protein CTD PMID:33049310 fluoranthene multiple interactions ISO RGD:69168 6480464 fluoranthene binds to and results in increased activity of PPARG protein CTD PMID:33049310 fluoxastrobin multiple interactions ISO RGD:69168 6480464 fluoxastrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 fluoxetine multiple interactions ISO RGD:69168 6480464 Fluoxetine inhibits the reaction [Serotonin results in increased localization of PPARG protein] CTD PMID:25766885 fluprostenol multiple interactions EXP 6480464 fluprostenol inhibits the reaction [Niacin results in increased expression of PPARG mRNA] CTD PMID:21236357 flutamide multiple interactions ISO RGD:69168 6480464 Flutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 flutamide multiple interactions EXP 6480464 Flutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 fluticasone multiple interactions ISO RGD:69168 6480464 Fluticasone promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]] CTD PMID:15531761 flutolanil increases activity ISO RGD:69168 6480464 flutolanil results in increased activity of PPARG protein CTD PMID:20143881 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPARG mRNA CTD PMID:22206623 folic acid multiple interactions ISO RGD:3371 6480464 [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA], Folic Acid inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:23935743 fomepizole multiple interactions ISO RGD:69168 6480464 fomepizole inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] CTD PMID:17030193 fructose increases expression ISO RGD:3371 6480464 Fructose results in increased expression of PPARG mRNA CTD PMID:19196556 fructose decreases activity ISO RGD:3371 6480464 Fructose results in decreased activity of PPARG protein CTD PMID:25679220 fructose multiple interactions ISO RGD:3371 6480464 [Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein more ... CTD PMID:19196556 more ... fucoxanthin decreases expression EXP 6480464 fucoxanthin results in decreased expression of PPARG mRNA CTD PMID:20519145 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [Diethylstilbestrol results in increased activity of PPARG protein], fulvestrant inhibits the reaction [Diosgenin results in decreased expression of PPARG mRNA] CTD PMID:22710028 , PMID:26408789 fulvestrant multiple interactions ISO RGD:69168 6480464 Fulvestrant inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA], PPARG protein affects the reaction [Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]] CTD PMID:32623698 fumonisin B2 decreases activity ISO RGD:69168 6480464 fumonisin B2 results in decreased activity of PPARG protein CTD PMID:27481073 furan decreases expression ISO RGD:3371 6480464 furan results in decreased expression of PPARG mRNA CTD PMID:25539665 , PMID:26194646 Fusarenone X decreases activity ISO RGD:69168 6480464 fusarenon-X results in decreased activity of PPARG protein CTD PMID:27481073 gallic acid increases expression EXP 6480464 Gallic Acid results in increased expression of PPARG protein CTD PMID:24036142 gallic acid increases activity ISO RGD:3371 6480464 Gallic Acid results in increased activity of PPARG protein CTD PMID:24433871 gallocatechin decreases expression ISO RGD:3371 6480464 gallocatechol results in decreased expression of PPARG mRNA CTD PMID:21877759 gamma-linolenic acid multiple interactions ISO RGD:69168 6480464 gamma-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:15318936 gamma-tocopherol increases expression ISO RGD:69168 6480464 gamma-Tocopherol results in increased expression of PPARG mRNA, gamma-Tocopherol results in increased expression of PPARG protein CTD PMID:14521714 gamma-tocopherol multiple interactions ISO RGD:3371 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 Ganoderic acid A multiple interactions EXP 6480464 [Dietary Fats co-treated with ganoderic acid A] affects the expression of PPARG mRNA CTD PMID:29852127 gemcitabine affects expression EXP 6480464 gemcitabine affects the expression of PPARG mRNA CTD PMID:19427843 gemfibrozil increases expression ISO RGD:69168 6480464 Gemfibrozil results in increased expression of PPARG mRNA CTD PMID:19201410 gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of PPARG mRNA CTD PMID:19201410 genistein decreases expression EXP 6480464 Genistein results in decreased expression of PPARG mRNA CTD PMID:18359623 genistein increases expression ISO RGD:3371 6480464 Genistein results in increased expression of PPARG mRNA CTD PMID:24361872 genistein decreases expression ISO RGD:69168 6480464 Genistein results in decreased expression of PPARG mRNA CTD PMID:20706672 genistein increases activity ISO RGD:3371 6480464 Genistein results in increased activity of PPARG protein CTD PMID:19903033 genistein multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:19903033 , PMID:27171397 geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [[lipopolysaccharide more ... CTD PMID:30550845 geraniol multiple interactions ISO RGD:3371 6480464 geraniol inhibits the reaction [Fructose results in decreased activity of PPARG protein] more ... CTD PMID:25679220 , PMID:26165751 geraniol increases activity ISO RGD:69168 6480464 geraniol results in increased activity of PPARG protein CTD PMID:21597168 geraniol decreases expression ISO RGD:69168 6480464 geraniol results in decreased expression of PPARG mRNA CTD PMID:27683099 gingerol multiple interactions EXP 6480464 gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG mRNA] more ... CTD PMID:22285432 , PMID:26498061 gingerol decreases expression EXP 6480464 gingerol results in decreased expression of PPARG mRNA, gingerol results in decreased expression of PPARG protein CTD PMID:26498061 ginsenoside Re increases expression EXP 6480464 ginsenoside Re results in increased expression of PPARG mRNA CTD PMID:23545455 Ginsenoside Rh4 multiple interactions EXP 6480464 ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PPARG mRNA] CTD PMID:33359794 gliclazide multiple interactions ISO RGD:3371 6480464 Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of PPARG protein] CTD PMID:32045587 glucose multiple interactions ISO RGD:3371 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... glucose decreases expression ISO RGD:69168 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 glucose multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 more ... glucose decreases expression ISO RGD:3371 6480464 Glucose results in decreased expression of PPARG mRNA, Glucose results in decreased expression of PPARG protein CTD PMID:19609456 , PMID:31063766 Glutathione ethyl ester multiple interactions EXP 6480464 S-ethyl glutathione inhibits the reaction [Buthionine Sulfoximine results in increased expression of PPARG mRNA] CTD PMID:21520053 glyburide multiple interactions ISO RGD:3371 6480464 Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA], Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] CTD PMID:29223569 glycerol multiple interactions ISO RGD:3371 6480464 ciglitazone inhibits the reaction [Glycerol results in decreased expression of PPARG protein] CTD PMID:16820301 glycerol decreases expression ISO RGD:3371 6480464 Glycerol results in decreased expression of PPARG protein CTD PMID:16820301 glycerol 2-phosphate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:14505802 , PMID:32473317 glycerol 2-phosphate multiple interactions ISO RGD:69168 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA CTD PMID:25932594 glycine increases expression EXP 6480464 Glycine results in increased expression of PPARG mRNA CTD PMID:18930730 glycycoumarin affects binding ISO RGD:69168 6480464 glycycoumarin binds to PPARG protein CTD PMID:14608046 glycyrrhetinate multiple interactions ISO RGD:3371 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA], 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein] CTD PMID:28414158 glycyrrhetinic acid multiple interactions ISO RGD:3371 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA], 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein] CTD PMID:28414158 glycyrrhizinic acid multiple interactions EXP 6480464 Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] CTD PMID:34302803 gossypetin affects response to substance EXP 6480464 PPARG protein affects the susceptibility to gossypetin CTD PMID:23845592 griseofulvin increases expression EXP 6480464 Griseofulvin results in increased expression of PPARG mRNA CTD PMID:9548566 GW 1929 increases activity ISO RGD:69168 6480464 GW 1929 results in increased activity of PPARG protein CTD PMID:21543282 GW 1929 increases expression ISO RGD:3371 6480464 GW 1929 results in increased expression of PPARG mRNA CTD PMID:19420904 GW 1929 multiple interactions EXP 6480464 4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide inhibits the reaction [GW 1929 results in increased expression of PPARG mRNA] more ... CTD PMID:12847270 more ... GW 1929 increases expression EXP 6480464 GW 1929 results in increased expression of PPARG mRNA CTD PMID:20516370 GW 1929 multiple interactions ISO RGD:69168 6480464 [GW 1929 binds to and results in increased activity of PPARG protein] promotes the reaction [TNF protein results in decreased susceptibility to FSHB protein] more ... CTD PMID:20008677 more ... GW 1929 affects binding ISO RGD:69168 6480464 GW 1929 binds to PPARG protein CTD PMID:20008677 more ... GW 4064 increases expression ISO RGD:3371 6480464 GW 4064 results in increased expression of PPARG mRNA CTD PMID:15980055 GW 4064 multiple interactions ISO RGD:69168 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of PPARG mRNA CTD PMID:30611723 GW 4064 increases expression ISO RGD:69168 6480464 GW 4064 results in increased expression of PPARG mRNA CTD PMID:30611723 GW 501516 increases expression ISO RGD:69168 6480464 GW 501516 results in increased expression of PPARG mRNA CTD PMID:19201410 GW 501516 increases expression EXP 6480464 GW 501516 results in increased expression of PPARG mRNA CTD PMID:19201410 GW 501516 increases activity ISO RGD:69168 6480464 GW 501516 results in increased activity of PPARG protein CTD PMID:16386710 GW 7647 multiple interactions ISO RGD:69168 6480464 GW 7647 binds to and results in increased activity of PPARG protein, PPARG protein promotes the reaction [GW 7647 results in increased activity of DIO2 protein] CTD PMID:19036883 GW 7647 multiple interactions EXP 6480464 [PPARA protein co-treated with GW 7647] results in increased expression of PPARG mRNA CTD PMID:21324916 GW 7647 increases activity ISO RGD:69168 6480464 GW 7647 results in increased activity of PPARG protein CTD PMID:20143881 harmine multiple interactions EXP 6480464 [phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA CTD PMID:20519739 harmine increases expression EXP 6480464 Harmine results in increased expression of PPARG protein CTD PMID:27805061 hesperetin decreases expression ISO RGD:69168 6480464 hesperetin results in decreased expression of PPARG mRNA, hesperetin results in decreased expression of PPARG protein CTD PMID:25345581 hesperetin multiple interactions EXP 6480464 [hesperetin analog co-treated with PPARG protein] affects the reaction [Lipopolysaccharides results in increased expression of TNF protein] more ... CTD PMID:28428136 hesperidin multiple interactions ISO RGD:3371 6480464 Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]] more ... CTD PMID:24954035 more ... hesperidin multiple interactions EXP 6480464 Hesperidin affects the reaction [LEPR protein affects the expression of PPARG protein] CTD PMID:16427799 HET0016 multiple interactions ISO RGD:3371 6480464 HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]] CTD PMID:31063766 hexadecanoic acid increases expression EXP 6480464 Palmitic Acid results in increased expression of PPARG mRNA, Palmitic Acid results in increased expression of PPARG protein CTD PMID:18154422 , PMID:30208301 hexadecanoic acid multiple interactions ISO RGD:69168 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA more ... CTD PMID:30208301 , PMID:32613381 hexadecanoic acid increases expression ISO RGD:69168 6480464 Palmitic Acid results in increased expression of PPARG protein CTD PMID:30208301 hexadecanoic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of PPARG mRNA more ... CTD PMID:30208301 , PMID:34968464 hexadecanoic acid multiple interactions ISO RGD:3371 6480464 [Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] more ... CTD PMID:25048947 more ... hexadecanoic acid decreases expression ISO RGD:3371 6480464 Palmitic Acid results in decreased expression of PPARG mRNA CTD PMID:25108154 hispidulin multiple interactions EXP 6480464 hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA], hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG protein] CTD PMID:30055130 Honokiol multiple interactions ISO RGD:69168 6480464 ALOX15 protein promotes the reaction [honokiol results in decreased expression of PPARG protein], honokiol binds to and results in increased activity of PPARG protein CTD PMID:20649594 , PMID:23811337 Honokiol decreases expression EXP 6480464 honokiol results in decreased expression of PPARG protein CTD PMID:20649594 Honokiol decreases expression ISO RGD:69168 6480464 honokiol results in decreased expression of PPARG mRNA, honokiol results in decreased expression of PPARG protein CTD PMID:20649594 hydrazine decreases expression ISO RGD:3371 6480464 hydrazine results in decreased expression of PPARG mRNA CTD PMID:15370871 hydrazines decreases expression EXP 6480464 Hydrazines results in decreased expression of PPARG mRNA, Hydrazines results in decreased expression of PPARG protein CTD PMID:21647536 hydrogen peroxide increases expression ISO RGD:69168 6480464 Hydrogen Peroxide results in increased expression of PPARG mRNA CTD PMID:25130202 hydrogen peroxide increases degradation ISO RGD:69168 6480464 Hydrogen Peroxide results in increased degradation of PPARG protein CTD PMID:25305479 hydrogen peroxide decreases expression ISO RGD:69168 6480464 Hydrogen Peroxide results in decreased expression of PPARG protein CTD PMID:27417252 , PMID:34499403 hydrogen peroxide affects abundance EXP 6480464 PPARG protein affects the abundance of Hydrogen Peroxide CTD PMID:18083318 hydrogen peroxide decreases abundance EXP 6480464 PPARG gene polymorphism results in decreased abundance of Hydrogen Peroxide CTD PMID:18083318 hydrogen peroxide multiple interactions ISO RGD:3371 6480464 stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] CTD PMID:17302992 hydrogen peroxide decreases expression ISO RGD:3371 6480464 Hydrogen Peroxide results in decreased expression of PPARG protein CTD PMID:17302992 hydrogen peroxide affects expression ISO RGD:69168 6480464 Hydrogen Peroxide affects the expression of PPARG mRNA CTD PMID:20044591 hydrogen peroxide multiple interactions ISO RGD:69168 6480464 bergenin inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] more ... CTD PMID:17030193 more ... hydroxyflutamide multiple interactions EXP 6480464 hydroxyflutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 hydroxyflutamide multiple interactions ISO RGD:69168 6480464 hydroxyflutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 hydroxysafflor yellow A multiple interactions ISO RGD:3371 6480464 hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein]] more ... CTD PMID:24192212 hydroxytyrosol decreases expression EXP 6480464 3, 4-dihydroxyphenylethanol results in decreased expression of PPARG mRNA CTD PMID:21569430 ibuprofen multiple interactions EXP 6480464 Ibuprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA], Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of PPARG protein] CTD PMID:16407166 , PMID:18946735 ibuprofen affects activity ISO RGD:3371 6480464 Ibuprofen affects the activity of PPARG protein CTD PMID:25596134 ibuprofen affects activity ISO RGD:69168 6480464 Ibuprofen affects the activity of PPARG protein CTD PMID:25596134 ibuprofen increases expression EXP 6480464 Ibuprofen results in increased expression of PPARG mRNA CTD PMID:16407166 ibuprofen increases activity ISO RGD:3371 6480464 Ibuprofen analog results in increased activity of PPARG protein CTD PMID:11755111 ibuprofen multiple interactions ISO RGD:69168 6480464 Ibuprofen binds to and results in increased activity of PPARG protein CTD PMID:9013583 idarubicin decreases activity ISO RGD:69168 6480464 Idarubicin results in decreased activity of PPARG protein CTD PMID:25257666 ifosfamide affects activity ISO RGD:69168 6480464 Ifosfamide affects the activity of PPARG protein CTD PMID:25596134 indinavir decreases expression EXP 6480464 Indinavir results in decreased expression of PPARG mRNA CTD PMID:17926646 indole-3-methanol affects expression ISO RGD:3371 6480464 indole-3-carbinol affects the expression of PPARG mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:12485869 more ... indometacin multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA more ... CTD PMID:30055130 , PMID:33412187 indometacin increases activity ISO RGD:69168 6480464 Indomethacin analog results in increased activity of PPARG protein, Indomethacin results in increased activity of PPARG protein CTD PMID:12065695 more ... indometacin increases activity ISO RGD:3371 6480464 Indomethacin results in increased activity of PPARG protein CTD PMID:11755111 indometacin multiple interactions ISO RGD:3371 6480464 Indomethacin inhibits the reaction [rosiglitazone binds to and affects the activity of PPARG protein] CTD PMID:12897060 indometacin increases activity EXP 6480464 Indomethacin results in increased activity of PPARG protein CTD PMID:11683414 indometacin increases expression ISO RGD:69168 6480464 Indomethacin results in increased expression of PPARG mRNA, Indomethacin results in increased expression of PPARG protein CTD PMID:12483719 more ... indometacin affects localization ISO RGD:69168 6480464 Indomethacin affects the localization of PPARG protein CTD PMID:15899809 Ingenol 3,20-dibenzoate increases activity ISO RGD:69168 6480464 ingenol dibenzoate results in increased activity of PPARG protein CTD PMID:15707588 iohexol increases expression ISO RGD:69168 6480464 Iohexol results in increased expression of PPARG mRNA CTD PMID:29705293 iprodione increases activity ISO RGD:69168 6480464 iprodione results in increased activity of PPARG protein CTD PMID:20143881 iprodione multiple interactions EXP 6480464 iprodione binds to and results in increased activity of PPARG protein CTD PMID:33049310 iprodione multiple interactions ISO RGD:69168 6480464 iprodione binds to and results in increased activity of PPARG protein CTD PMID:33049310 irinotecan multiple interactions ISO RGD:69168 6480464 Luteolin inhibits the reaction [Irinotecan results in decreased expression of PPARG mRNA] more ... CTD PMID:34699766 irinotecan decreases expression ISO RGD:69168 6480464 Irinotecan results in decreased expression of PPARG mRNA CTD PMID:34699766 iron atom increases expression ISO RGD:69168 6480464 Iron deficiency results in increased expression of PPARG mRNA CTD PMID:20368581 iron(0) increases expression ISO RGD:69168 6480464 Iron deficiency results in increased expression of PPARG mRNA CTD PMID:20368581 isoliquiritigenin multiple interactions EXP 6480464 isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of PPARG protein] CTD PMID:27117918 isoniazide decreases expression EXP 6480464 Isoniazid results in decreased expression of PPARG mRNA, Isoniazid results in decreased expression of PPARG protein CTD PMID:24128855 isoniazide decreases expression ISO RGD:69168 6480464 Isoniazid results in decreased expression of PPARG mRNA CTD PMID:24128855 isonicotinamide decreases expression EXP 6480464 isonicotinamide results in decreased expression of PPARG mRNA CTD PMID:16813520 isophorone multiple interactions ISO RGD:69168 6480464 isophorone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 isoprenaline multiple interactions ISO RGD:3371 6480464 2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein] more ... CTD PMID:24954035 , PMID:30623541 isoprenaline decreases expression ISO RGD:3371 6480464 Isoproterenol results in decreased expression of PPARG mRNA, Isoproterenol results in decreased expression of PPARG protein CTD PMID:24286936 , PMID:30623541 isoprenaline multiple interactions EXP 6480464 osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA] CTD PMID:21854795 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of PPARG mRNA CTD PMID:21854795 isorhamnetin multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [3-methylquercetin results in increased activity of PPARG protein], 3-methylquercetin binds to and results in increased activity of PPARG protein CTD PMID:22992727 isorhamnetin increases expression ISO RGD:69168 6480464 3-methylquercetin results in increased expression of PPARG protein CTD PMID:22992727 isotretinoin increases expression ISO RGD:3371 6480464 Isotretinoin results in increased expression of PPARG mRNA CTD PMID:19041696 , PMID:19212007 ivermectin multiple interactions EXP 6480464 Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein], Rosiglitazone affects the reaction [Ivermectin affects the expression of PPARG mRNA] CTD PMID:31199990 ivermectin affects expression EXP 6480464 Ivermectin affects the expression of PPARG mRNA CTD PMID:31199990 juglone increases expression ISO RGD:69168 6480464 juglone results in increased expression of PPARG mRNA, juglone results in increased expression of PPARG protein CTD PMID:31916655 juglone multiple interactions ISO RGD:69168 6480464 [Indomethacin co-treated with juglone] results in increased expression of PPARG mRNA, [Indomethacin co-treated with juglone] results in increased expression of PPARG protein CTD PMID:31916655 kaempferol multiple interactions EXP 6480464 kaempferol binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 more ... kaempferol increases expression ISO RGD:69168 6480464 kaempferol results in increased expression of PPARG mRNA, kaempferol results in increased expression of PPARG protein CTD PMID:25765892 kaempferol multiple interactions ISO RGD:69168 6480464 kaempferol binds to and results in increased activity of PPARG protein CTD PMID:33049310 kresoxim-methyl multiple interactions ISO RGD:69168 6480464 kresoxim-methyl inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:14505802 , PMID:32473317 L-ascorbic acid multiple interactions ISO RGD:69168 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA CTD PMID:25932594 L-methionine multiple interactions EXP 6480464 3 more ... CTD PMID:18991162 , PMID:28973532 lacidipine increases activity ISO RGD:69168 6480464 lacidipine results in increased activity of PPARG protein CTD PMID:25257666 lead diacetate multiple interactions ISO RGD:3371 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 , PMID:28283887 lead diacetate increases expression ISO RGD:3371 6480464 lead acetate results in increased expression of PPARG protein CTD PMID:28283887 lead(0) increases expression ISO RGD:3371 6480464 Lead results in increased expression of PPARG mRNA CTD PMID:23086611 lead(0) increases expression EXP 6480464 Lead results in increased expression of PPARG, Lead results in increased expression of PPARG mRNA CTD PMID:23086611 , PMID:26518054 lead(2+) increases expression ISO RGD:3371 6480464 Lead results in increased expression of PPARG mRNA CTD PMID:23086611 lead(2+) increases expression EXP 6480464 Lead results in increased expression of PPARG, Lead results in increased expression of PPARG mRNA CTD PMID:23086611 , PMID:26518054 leflunomide increases expression ISO RGD:69168 6480464 leflunomide results in increased expression of PPARG mRNA CTD PMID:28988120 letrozole decreases expression ISO RGD:3371 6480464 Letrozole results in decreased expression of PPARG mRNA CTD PMID:33491863 letrozole multiple interactions ISO RGD:3371 6480464 ADM protein inhibits the reaction [Letrozole results in decreased expression of PPARG mRNA] CTD PMID:33491863 Licarin A multiple interactions EXP 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA, [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein CTD PMID:29288687 linoleamide increases activity ISO RGD:69168 6480464 linoleamide analog results in increased activity of PPARG protein CTD PMID:29288688 linoleic acid affects binding ISO RGD:69168 6480464 Linoleic Acid binds to PPARG protein CTD PMID:23843199 , PMID:35752307 linoleic acid affects binding EXP 6480464 Linoleic Acid binds to PPARG protein CTD PMID:12021203 linoleic acid multiple interactions ISO RGD:3371 6480464 Linoleic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 linoleic acid increases expression EXP 6480464 Linoleic Acid results in increased expression of PPARG mRNA CTD PMID:18154422 linoleic acid multiple interactions EXP 6480464 Linoleic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 linoleic acid multiple interactions ISO RGD:69168 6480464 resveratrol inhibits the reaction [Linoleic Acid results in increased expression of PPARG protein] CTD PMID:25672876 linoleic acid increases expression ISO RGD:69168 6480464 Linoleic Acid results in increased expression of PPARG protein CTD PMID:25672876 linoleic acid increases activity ISO RGD:69168 6480464 Linoleic Acid results in increased activity of PPARG protein CTD PMID:25786526 linoleic acid decreases expression ISO RGD:69168 6480464 Linoleic Acid results in decreased expression of PPARG mRNA, Linoleic Acid results in decreased expression of PPARG protein CTD PMID:11172467 , PMID:15708366 linuron multiple interactions EXP 6480464 Linuron binds to and results in increased activity of PPARG protein CTD PMID:33049310 linuron multiple interactions ISO RGD:69168 6480464 Linuron binds to and results in increased activity of PPARG protein CTD PMID:33049310 lipoic acid multiple interactions ISO RGD:3371 6480464 [Thioctic Acid co-treated with Dietary Fats] results in increased expression of PPARG mRNA CTD PMID:22464149 lipopolysaccharide multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:15318101 more ... lipopolysaccharide decreases activity ISO RGD:3371 6480464 Lipopolysaccharides results in decreased activity of PPARG protein CTD PMID:29480285 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of PPARG mRNA, Lipopolysaccharides results in decreased expression of PPARG protein CTD PMID:16847310 more ... lipopolysaccharide decreases expression ISO RGD:69168 6480464 Lipopolysaccharides results in decreased expression of PPARG mRNA CTD PMID:12604364 lipopolysaccharide multiple interactions ISO RGD:69168 6480464 15-deoxy-delta(12 more ... CTD PMID:12604364 more ... lipopolysaccharide multiple interactions EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:11343698 more ... lipopolysaccharide increases activity EXP 6480464 Lipopolysaccharides results in increased activity of PPARG protein CTD PMID:27329536 lipoxin A4 multiple interactions ISO RGD:3371 6480464 lipoxin A4 binds to and results in increased activity of PPARG protein CTD PMID:19321784 lithium chloride increases expression ISO RGD:69168 6480464 Lithium Chloride results in increased expression of PPARG mRNA CTD PMID:23527032 losartan multiple interactions ISO RGD:3371 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of PPARG mRNA] CTD PMID:19109942 losartan multiple interactions EXP 6480464 Losartan inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA] CTD PMID:18302760 lovastatin affects localization ISO RGD:69168 6480464 Lovastatin analog affects the localization of PPARG protein CTD PMID:26863638 lovastatin multiple interactions ISO RGD:3371 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] more ... CTD PMID:20578043 lovastatin increases expression ISO RGD:3371 6480464 Lovastatin results in increased expression of PPARG mRNA CTD PMID:20578043 lovastatin multiple interactions EXP 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of PPARG mRNA, PPARG affects the reaction [Lovastatin results in increased expression of PTEN protein] CTD PMID:16425225 , PMID:29852127 lovastatin multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein] more ... CTD PMID:16425225 , PMID:26863638 luteolin multiple interactions ISO RGD:69168 6480464 Luteolin inhibits the reaction [Irinotecan results in decreased expression of PPARG mRNA] more ... CTD PMID:34699766 luteolin increases expression ISO RGD:69168 6480464 Luteolin results in increased expression of PPARG mRNA CTD PMID:34699766 luzindole multiple interactions ISO RGD:69168 6480464 luzindole inhibits the reaction [Melatonin results in increased expression of PPARG protein], luzindole inhibits the reaction [Pioglitazone results in increased expression of PPARG protein] CTD PMID:29734669 LY294002 increases expression ISO RGD:3371 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG mRNA, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG protein CTD PMID:17372590 m-xylene decreases expression ISO RGD:3371 6480464 3-xylene results in decreased expression of PPARG mRNA CTD PMID:12815608 Magnolol multiple interactions EXP 6480464 2 more ... CTD PMID:20064974 Magnolol multiple interactions ISO RGD:69168 6480464 magnolol binds to and results in increased activity of PPARG protein CTD PMID:20064974 manganese atom multiple interactions ISO RGD:3371 6480464 [1, 1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] CTD PMID:18041089 manganese(0) multiple interactions ISO RGD:3371 6480464 [1, 1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] CTD PMID:18041089 mangiferin multiple interactions ISO RGD:3371 6480464 mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA], mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] CTD PMID:29223569 mangiferin multiple interactions EXP 6480464 [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein CTD PMID:32417366 manidipine decreases activity ISO RGD:69168 6480464 manidipine results in decreased activity of PPARG protein CTD PMID:25257666 melatonin decreases expression ISO RGD:69168 6480464 Melatonin results in decreased expression of PPARG mRNA CTD PMID:20738756 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Cisplatin results in decreased expression of PPARG protein] CTD PMID:34428482 melatonin multiple interactions ISO RGD:69168 6480464 GW 1929 inhibits the reaction [Melatonin results in increased expression of PPARG protein] more ... CTD PMID:29734669 melatonin increases expression ISO RGD:69168 6480464 Melatonin results in increased expression of PPARG mRNA, Melatonin results in increased expression of PPARG protein CTD PMID:29734669 , PMID:33962019 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of PPARG mRNA, Mercuric Chloride results in decreased expression of PPARG protein CTD PMID:12883084 , PMID:22019852 mercury dichloride increases expression ISO RGD:3371 6480464 Mercuric Chloride results in increased expression of PPARG mRNA CTD PMID:30807803 mesalamine multiple interactions EXP 6480464 Mesalamine inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein] CTD PMID:33130971 mesalamine multiple interactions ISO RGD:69168 6480464 [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Mesalamine] results in increased expression of PPARG protein, Mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of PPARG protein] CTD PMID:27818126 metconazole multiple interactions ISO RGD:69168 6480464 metconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 metconazole multiple interactions EXP 6480464 metconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 metformin decreases expression ISO RGD:69168 6480464 Metformin results in decreased expression of PPARG mRNA CTD PMID:20956498 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [IL13 protein results in increased expression of PPARG mRNA] CTD PMID:26497364 metformin affects activity ISO RGD:3371 6480464 Metformin affects the activity of PPARG protein CTD PMID:25596134 metformin multiple interactions ISO RGD:3371 6480464 Metformin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein], Metformin inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] CTD PMID:25108154 , PMID:30256492 metformin increases expression EXP 6480464 Metformin results in increased expression of PPARG mRNA CTD PMID:21870829 metformin increases expression ISO RGD:3371 6480464 Metformin results in increased expression of PPARG mRNA CTD PMID:20724125 methamphetamine multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide promotes the reaction [PPARG protein results in increased susceptibility to Methamphetamine] more ... CTD PMID:17019405 , PMID:18946735 methamphetamine increases response to substance EXP 6480464 PPARG protein results in increased susceptibility to Methamphetamine CTD PMID:17019405 methamphetamine increases activity EXP 6480464 Methamphetamine results in increased activity of PPARG protein CTD PMID:17019405 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of PPARG protein CTD PMID:17019405 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of PPARG protein CTD PMID:18946735 methotrexate multiple interactions ISO RGD:3371 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA] more ... CTD PMID:25187349 more ... methotrexate decreases expression ISO RGD:3371 6480464 Methotrexate results in decreased expression of PPARG mRNA, Methotrexate results in decreased expression of PPARG protein CTD PMID:28414158 , PMID:34737150 methotrexate increases expression ISO RGD:3371 6480464 Methotrexate results in increased expression of PPARG protein CTD PMID:25187349 methyl beta-cyclodextrin multiple interactions EXP 6480464 methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]] CTD PMID:16971554 methyl laurate multiple interactions ISO RGD:69168 6480464 lauric acid methyl ester binds to and results in decreased activity of PPARG protein CTD PMID:27633901 methyl oleate multiple interactions ISO RGD:69168 6480464 methyl oleate binds to and results in increased activity of PPARG protein CTD PMID:27633901 methylglyoxal multiple interactions ISO RGD:3371 6480464 PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1 more ... CTD PMID:23954466 methylisothiazolinone increases expression ISO RGD:69168 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of PPARG mRNA CTD PMID:31629900 methylparaben multiple interactions ISO RGD:69168 6480464 methylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 methylparaben multiple interactions EXP 6480464 PPARG protein promotes the reaction [methylparaben results in decreased expression of BGLAP mRNA] CTD PMID:28527915 methylparaben increases response to substance EXP 6480464 PPARG protein results in increased susceptibility to methylparaben CTD PMID:28527915 metolachlor multiple interactions EXP 6480464 metolachlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 metolachlor multiple interactions ISO RGD:69168 6480464 metolachlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA], Mifepristone inhibits the reaction [butylparaben results in increased expression of PPARG mRNA] CTD PMID:22956630 , PMID:27145005 mifepristone multiple interactions ISO RGD:3371 6480464 Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein] CTD PMID:30229846 mifepristone decreases expression ISO RGD:3371 6480464 Mifepristone results in decreased expression of PPARG mRNA CTD PMID:25972201 miquelianin increases expression ISO RGD:69168 6480464 quercetin 3-O-glucuronide results in increased expression of PPARG mRNA CTD PMID:25765892 Mitotane multiple interactions EXP 6480464 Mitotane binds to and results in increased activity of PPARG protein CTD PMID:33049310 monascin increases response to substance ISO RGD:3371 6480464 PPARG protein results in increased susceptibility to monascin CTD PMID:23954466 monascin increases expression ISO RGD:69168 6480464 monascin results in increased expression of PPARG protein CTD PMID:22381257 monascin multiple interactions ISO RGD:3371 6480464 PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1 more ... CTD PMID:23954466 monascin affects localization ISO RGD:69168 6480464 monascin affects the localization of PPARG protein CTD PMID:23954466 monascin decreases phosphorylation ISO RGD:69168 6480464 monascin results in decreased phosphorylation of PPARG protein CTD PMID:22381257 mono(2-ethyl-5-oxohexyl) phthalate multiple interactions ISO RGD:69168 6480464 mono(2-ethyl-5-oxohexyl)phthalate binds to and affects the folding of and results in increased activity of PPARG protein CTD PMID:30085373 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:12927354 more ... mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA, mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein CTD PMID:31884101 , PMID:33049310 mono(2-ethylhexyl) phthalate affects activity ISO RGD:69168 6480464 mono-(2-ethylhexyl)phthalate affects the activity of PPARG protein CTD PMID:30810372 mono(2-ethylhexyl) phthalate affects expression ISO RGD:69168 6480464 mono-(2-ethylhexyl)phthalate affects the expression of PPARG mRNA CTD PMID:30810372 mono(2-ethylhexyl) phthalate increases activity ISO RGD:69168 6480464 mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein CTD PMID:10581215 more ... mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA CTD PMID:25543134 mono(2-ethylhexyl) phthalate affects binding ISO RGD:69168 6480464 mono-(2-ethylhexyl)phthalate binds to PPARG protein CTD PMID:23843199 , PMID:35019730 mono(2-ethylhexyl) phthalate increases activity EXP 6480464 mono-(2-ethylhexyl)phthalate analog results in increased activity of PPARG protein, mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein CTD PMID:10581215 more ... mono(2-ethylhexyl) phthalate decreases expression ISO RGD:69168 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA CTD PMID:23118965 mono(2-ethylhexyl) phthalate increases expression ISO RGD:3371 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of PPARG mRNA, mono-(2-ethylhexyl)phthalate results in increased expression of PPARG protein CTD PMID:15647598 monobenzyl phthalate affects binding ISO RGD:69168 6480464 mono-benzyl phthalate binds to PPARG protein CTD PMID:23843199 monobenzyl phthalate multiple interactions EXP 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA CTD PMID:31884101 monobenzyl phthalate increases expression ISO RGD:69168 6480464 mono-benzyl phthalate results in increased expression of PPARG protein CTD PMID:29089286 monobenzyl phthalate increases activity ISO RGD:69168 6480464 mono-benzyl phthalate results in increased activity of PPARG protein CTD PMID:27551952 Monobutylphthalate affects binding ISO RGD:69168 6480464 monobutyl phthalate binds to PPARG protein CTD PMID:23843199 Monobutylphthalate affects expression ISO RGD:69168 6480464 monobutyl phthalate affects the expression of PPARG mRNA CTD PMID:28381288 Monobutylphthalate increases expression ISO RGD:69168 6480464 monobutyl phthalate results in increased expression of PPARG protein CTD PMID:29089286 Monobutylphthalate multiple interactions ISO RGD:69168 6480464 monobutyl phthalate inhibits the reaction [ciglitazone binds to and results in increased activity of PPARG protein] CTD PMID:16326050 monocrotophos increases expression ISO RGD:3371 6480464 Monocrotophos results in increased expression of PPARG mRNA CTD PMID:32267039 monoethyl phthalate affects binding ISO RGD:69168 6480464 monoethyl phthalate binds to PPARG protein CTD PMID:23843199 monoethyl phthalate multiple interactions EXP 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA CTD PMID:31884101 monoethyl phthalate affects expression ISO RGD:69168 6480464 monoethyl phthalate affects the expression of PPARG mRNA CTD PMID:28381288 monohexyl phthalate affects binding ISO RGD:69168 6480464 mono-n-hexyl phthalate binds to PPARG protein CTD PMID:23843199 Monomethyl phthalate affects binding ISO RGD:69168 6480464 monomethyl phthalate binds to PPARG protein CTD PMID:23843199 monooctyl phthalate affects binding ISO RGD:69168 6480464 mono-n-octyl phthalate binds to PPARG protein CTD PMID:23843199 monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of PPARG mRNA CTD PMID:21205225 monosodium L-glutamate multiple interactions EXP 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA CTD PMID:23783067 monosodium L-glutamate affects response to substance EXP 6480464 PPARG protein affects the susceptibility to Sodium Glutamate CTD PMID:15231871 Muraglitazar decreases expression ISO RGD:3371 6480464 muraglitazar results in decreased expression of PPARG mRNA CTD PMID:21515302 Muraglitazar multiple interactions EXP 6480464 muraglitazar binds to and results in increased activity of PPARG protein CTD PMID:17675651 Muraglitazar multiple interactions ISO RGD:69168 6480464 muraglitazar binds to and results in increased activity of PPARG protein CTD PMID:17426106 , PMID:17675651 myricitrin multiple interactions ISO RGD:69168 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of PPARG mRNA] CTD PMID:25130202 N(gamma)-nitro-L-arginine methyl ester multiple interactions EXP 6480464 ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of PPARG protein] CTD PMID:34995009 N(gamma)-nitro-L-arginine methyl ester decreases expression EXP 6480464 NG-Nitroarginine Methyl Ester results in decreased expression of PPARG protein CTD PMID:34995009 N-acetyl-L-cysteine increases expression ISO RGD:3371 6480464 Acetylcysteine results in increased expression of PPARG mRNA, Acetylcysteine results in increased expression of PPARG protein CTD PMID:17602960 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein], Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of PPARG protein] CTD PMID:22046279 , PMID:27117918 N-acetyl-L-cysteine multiple interactions ISO RGD:69168 6480464 Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species], Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] CTD PMID:16945329 , PMID:23964924 N-acetyl-L-cysteine multiple interactions ISO RGD:3371 6480464 Acetylcysteine inhibits the reaction [yttrium chloride results in decreased expression of PPARG protein] more ... CTD PMID:17602960 , PMID:35088107 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases activity ISO RGD:69168 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of PPARG protein CTD PMID:15707588 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of PPARG protein], benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein] CTD PMID:18555852 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:69168 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [15-deoxy-delta(12 more ... CTD PMID:15707588 N-butylbenzenesulfonamide multiple interactions ISO RGD:69168 6480464 N-butylbenzenesulfonamide binds to and results in decreased activity of PPARG protein CTD PMID:27633901 N-methyl-4-phenylpyridinium affects expression ISO RGD:69168 6480464 1-Methyl-4-phenylpyridinium affects the expression of PPARG mRNA CTD PMID:24767308 N-methyl-4-phenylpyridinium decreases expression ISO RGD:69168 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein CTD PMID:26141122 , PMID:30965670 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:69168 6480464 [1-Methyl-4-phenylpyridinium co-treated with PPARGC1A protein] results in increased expression of PPARG mRNA more ... CTD PMID:26141122 , PMID:30965670 N-methyl-N-nitrosourea increases response to substance EXP 6480464 PPARG gene mutant form results in increased susceptibility to Methylnitrosourea CTD PMID:15930296 N-methylnicotinate multiple interactions ISO RGD:69168 6480464 ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]], trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein] CTD PMID:30208301 N-methylnicotinate multiple interactions EXP 6480464 trigonelline inhibits the reaction [[Cholesterol more ... CTD PMID:30208301 N-nitrosodiethylamine decreases expression ISO RGD:3371 6480464 Diethylnitrosamine results in decreased expression of PPARG mRNA, Diethylnitrosamine results in decreased expression of PPARG protein CTD PMID:24954034 N-nitrosodiethylamine multiple interactions ISO RGD:3371 6480464 [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA more ... CTD PMID:28935427 , PMID:30298849 N-nitrosodiethylamine decreases response to substance EXP 6480464 PPARG protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:20512989 N-nitrosodimethylamine decreases expression ISO RGD:3371 6480464 Dimethylnitrosamine results in decreased expression of PPARG mRNA CTD PMID:12055599 , PMID:15099470 NAD zwitterion decreases activity ISO RGD:3371 6480464 NAD results in decreased activity of PPARG protein CTD PMID:18815186 NAD zwitterion multiple interactions ISO RGD:3371 6480464 3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein] CTD PMID:18815186 NAD(+) multiple interactions ISO RGD:3371 6480464 3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein] CTD PMID:18815186 NAD(+) decreases activity ISO RGD:3371 6480464 NAD results in decreased activity of PPARG protein CTD PMID:18815186 napropamide multiple interactions EXP 6480464 devrinol binds to and results in increased activity of PPARG protein CTD PMID:33049310 napropamide multiple interactions ISO RGD:69168 6480464 devrinol binds to and results in increased activity of PPARG protein CTD PMID:33049310 naproxen increases activity ISO RGD:3371 6480464 Naproxen results in increased activity of PPARG protein CTD PMID:11755111 naringin multiple interactions EXP 6480464 naringin affects the reaction [LEPR protein affects the expression of PPARG protein], naringin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA] CTD PMID:16427799 , PMID:22198281 naringin multiple interactions ISO RGD:3371 6480464 [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA], naringin inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA] CTD PMID:30130594 nevirapine increases expression ISO RGD:69168 6480464 Nevirapine results in increased expression of PPARG mRNA CTD PMID:21619898 nicardipine decreases activity ISO RGD:69168 6480464 Nicardipine results in decreased activity of PPARG protein CTD PMID:25257666 nickel atom decreases expression ISO RGD:69168 6480464 Nickel results in decreased expression of PPARG mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression ISO RGD:69168 6480464 nickel sulfate results in increased expression of PPARG mRNA CTD PMID:16314067 nicotinamide multiple interactions EXP 6480464 Niacinamide affects the reaction [PPARG protein binds to NCOR1 protein], resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein] CTD PMID:22539994 nicotinamide increases expression EXP 6480464 Niacinamide results in increased expression of PPARG protein CTD PMID:22539994 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of PPARG protein CTD PMID:33082140 nicotine increases expression EXP 6480464 Nicotine results in increased expression of PPARG mRNA CTD PMID:31622651 nicotinic acid multiple interactions ISO RGD:69168 6480464 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [Niacin results in increased activity of PPARG protein] more ... CTD PMID:15037193 , PMID:16386710 nicotinic acid increases expression ISO RGD:69168 6480464 Niacin results in increased expression of PPARG mRNA CTD PMID:15037193 more ... nicotinic acid increases expression EXP 6480464 Niacin results in increased expression of PPARG mRNA CTD PMID:19797938 nicotinic acid multiple interactions EXP 6480464 [Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG mRNA more ... CTD PMID:19797938 , PMID:21236357 Niflumic acid increases expression ISO RGD:69168 6480464 Niflumic Acid results in increased expression of PPARG protein CTD PMID:21067863 nilutamide multiple interactions EXP 6480464 nilutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 nilutamide multiple interactions ISO RGD:69168 6480464 nilutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 nimesulide multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide promotes the reaction [PPARG binds to PPARG promoter]] more ... CTD PMID:11840453 more ... nimesulide multiple interactions ISO RGD:3371 6480464 nimesulide inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:19247274 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of PPARG mRNA CTD PMID:15705899 nimesulide multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide results in increased expression of PPARG mRNA] CTD PMID:15705899 nimesulide increases expression ISO RGD:69168 6480464 nimesulide results in increased expression of PPARG protein CTD PMID:14977856 nimesulide decreases expression ISO RGD:69168 6480464 nimesulide results in decreased expression of PPARG mRNA CTD PMID:11840453 nitric oxide multiple interactions ISO RGD:69168 6480464 [rosiglitazone binds to and affects the activity of PPARG protein] which results in increased abundance of Nitric Oxide CTD PMID:16527820 nitric oxide multiple interactions ISO RGD:3371 6480464 [1, 1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] CTD PMID:18041089 nitric oxide increases expression ISO RGD:3371 6480464 Nitric Oxide deficiency results in increased expression of PPARG protein CTD PMID:17063326 nitric oxide multiple interactions EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:12847270 nitrofen decreases expression ISO RGD:3371 6480464 nitrofen results in decreased expression of PPARG mRNA, nitrofen results in decreased expression of PPARG protein CTD PMID:22595559 nitrofen increases expression ISO RGD:3371 6480464 nitrofen results in increased expression of PPARG mRNA CTD PMID:33484710 nitrofen multiple interactions ISO RGD:69168 6480464 nitrofen binds to and results in increased activity of PPARG protein CTD PMID:33049310 nitrofen multiple interactions EXP 6480464 nitrofen binds to and results in increased activity of PPARG protein CTD PMID:33049310 Nivalenol decreases activity ISO RGD:69168 6480464 nivalenol results in decreased activity of PPARG protein CTD PMID:27481073 nonanedioic acid increases expression ISO RGD:69168 6480464 azelaic acid results in increased expression of PPARG mRNA CTD PMID:20545756 nonanedioic acid increases activity ISO RGD:69168 6480464 azelaic acid results in increased activity of PPARG protein CTD PMID:20545756 Nonylphenol multiple interactions EXP 6480464 nonylphenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 Nonylphenol decreases expression ISO RGD:3371 6480464 nonylphenol results in decreased expression of PPARG protein CTD PMID:29641977 Nonylphenol multiple interactions ISO RGD:69168 6480464 nonylphenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 norathyriol multiple interactions ISO RGD:69168 6480464 norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein] CTD PMID:18393431 norethisterone multiple interactions EXP 6480464 Norethindrone binds to and results in increased activity of PPARG protein CTD PMID:33049310 notoginsenoside R1 multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [notoginsenoside R1 results in increased expression of PPARG] CTD PMID:25714973 notoginsenoside R1 increases expression EXP 6480464 notoginsenoside R1 results in increased expression of PPARG CTD PMID:25714973 NS-398 multiple interactions ISO RGD:69168 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Cannabidiol affects the localization of PPARG protein] more ... CTD PMID:11840453 more ... NS-398 increases localization ISO RGD:69168 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased localization of PPARG protein CTD PMID:12517972 NS-398 decreases expression ISO RGD:69168 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PPARG mRNA CTD PMID:11840453 o-cresol increases expression ISO RGD:3371 6480464 2-cresol results in increased expression of PPARG mRNA CTD PMID:21705299 o-cresol multiple interactions ISO RGD:3371 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA] CTD PMID:21705299 obeticholic acid increases expression ISO RGD:3371 6480464 obeticholic acid results in increased expression of PPARG mRNA, obeticholic acid results in increased expression of PPARG protein CTD PMID:15980055 ochratoxin A decreases expression ISO RGD:69168 6480464 ochratoxin A results in decreased expression of PPARG CTD PMID:20590410 ochratoxin A increases expression ISO RGD:69168 6480464 ochratoxin A results in increased expression of PPARG mRNA CTD PMID:32905824 ochratoxin A increases expression ISO RGD:3371 6480464 ochratoxin A results in increased expression of PPARG mRNA CTD PMID:15994020 ochratoxin A multiple interactions ISO RGD:3371 6480464 15-deoxy-delta(12 more ... CTD PMID:15994020 ochratoxin A increases phosphorylation ISO RGD:69168 6480464 ochratoxin A results in increased phosphorylation of PPARG protein CTD PMID:20590410 ochratoxin A decreases activity ISO RGD:69168 6480464 ochratoxin A results in decreased activity of PPARG protein CTD PMID:20590410 , PMID:27481073 octadecanoic acid multiple interactions ISO RGD:3371 6480464 stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] CTD PMID:17302992 octanoic acid multiple interactions EXP 6480464 [octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form, [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form] CTD PMID:14984747 octanoic acid affects binding ISO RGD:69168 6480464 octanoic acid binds to PPARG protein CTD PMID:35752307 octanoic acid affects binding ISO RGD:3371 6480464 octanoic acid binds to PPARG protein CTD PMID:35752307 Octicizer multiple interactions EXP 6480464 2-ethylhexyldiphenylphosphate binds to and results in increased activity of PPARG protein CTD PMID:31812418 Octicizer multiple interactions ISO RGD:69168 6480464 PPARG protein affects the reaction [2-ethylhexyldiphenylphosphate results in increased expression of HSD3B1 mRNA] CTD PMID:28282128 Octicizer increases activity ISO RGD:69168 6480464 2-ethylhexyldiphenylphosphate results in increased activity of PPARG protein CTD PMID:28282128 octocrylene affects binding ISO RGD:69168 6480464 octocrylene binds to PPARG protein CTD PMID:34864131 octocrylene multiple interactions ISO RGD:69168 6480464 octocrylene promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA] CTD PMID:34864131 octocrylene increases expression ISO RGD:69168 6480464 octocrylene results in increased expression of PPARG mRNA CTD PMID:34864131 olanzapine increases expression EXP 6480464 olanzapine results in increased expression of PPARG protein alternative form CTD PMID:17651982 oleamide increases activity ISO RGD:69168 6480464 oleylamide analog results in increased activity of PPARG protein CTD PMID:29288688 oleic acid increases expression EXP 6480464 Oleic Acid results in increased expression of PPARG mRNA CTD PMID:18154422 oleic acid affects binding ISO RGD:3371 6480464 Oleic Acid binds to PPARG protein CTD PMID:35752307 oleic acid multiple interactions ISO RGD:3371 6480464 [Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] more ... CTD PMID:25048947 more ... oleic acid multiple interactions ISO RGD:69168 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of PPARG mRNA more ... CTD PMID:24534255 more ... oleic acid affects binding ISO RGD:69168 6480464 Oleic Acid binds to PPARG protein CTD PMID:24998974 , PMID:35752307 oleic acid increases expression ISO RGD:69168 6480464 Oleic Acid results in increased expression of PPARG mRNA, Oleic Acid results in increased expression of PPARG protein CTD PMID:11172467 oleoyl-CoA multiple interactions ISO RGD:69168 6480464 oleoyl-coenzyme A binds to and results in increased activity of PPARG protein CTD PMID:11139385 oleuropein multiple interactions ISO RGD:3371 6480464 oleuropein inhibits the reaction [Cholesterol, Dietary results in increased expression of PPARG protein] CTD PMID:27019295 orientin multiple interactions EXP 6480464 orientin inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] CTD PMID:32044341 orlistat increases expression ISO RGD:69168 6480464 Orlistat results in increased expression of PPARG mRNA CTD PMID:32347045 oryzalin multiple interactions EXP 6480464 oryzalin binds to and results in increased activity of PPARG protein CTD PMID:33049310 oryzalin multiple interactions ISO RGD:69168 6480464 oryzalin binds to and results in increased activity of PPARG protein CTD PMID:33049310 Osajin decreases expression ISO RGD:69168 6480464 osajin results in decreased expression of PPARG mRNA CTD PMID:20706672 osthole increases expression EXP 6480464 osthol results in increased expression of PPARG mRNA, osthol results in increased expression of PPARG protein CTD PMID:19682441 osthole multiple interactions EXP 6480464 osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA] CTD PMID:21854795 Oxadiazon multiple interactions ISO RGD:69168 6480464 oxadiazon binds to and results in increased activity of PPARG protein CTD PMID:33049310 Oxadiazon multiple interactions EXP 6480464 oxadiazon binds to and results in increased activity of PPARG protein CTD PMID:33049310 oxaliplatin multiple interactions ISO RGD:3371 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PPARG mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:3371 6480464 oxaliplatin results in increased expression of PPARG mRNA CTD PMID:25729387 oxaprozin increases activity ISO RGD:69168 6480464 oxaprozin results in increased activity of PPARG protein CTD PMID:12065695 oxybenzone multiple interactions ISO RGD:69168 6480464 oxybenzone binds to and results in increased activity of PPARG protein more ... CTD PMID:32407875 more ... oxybenzone increases expression ISO RGD:69168 6480464 oxybenzone results in increased expression of PPARG mRNA CTD PMID:32407875 oxybenzone affects binding ISO RGD:69168 6480464 oxybenzone binds to PPARG protein CTD PMID:32407875 oxybenzone multiple interactions EXP 6480464 oxybenzone binds to and results in increased activity of PPARG protein CTD PMID:33049310 ozone increases expression ISO RGD:3371 6480464 Ozone results in increased expression of PPARG mRNA CTD PMID:16716893 , PMID:29329427 ozone multiple interactions ISO RGD:69168 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:3371 6480464 Fish Oils inhibits the reaction [Ozone results in increased expression of PPARG mRNA] CTD PMID:29329427 ozone decreases expression ISO RGD:3371 6480464 Ozone results in decreased expression of PPARG mRNA CTD PMID:33524448 p-tolualdehyde multiple interactions ISO RGD:69168 6480464 4-methylbenzaldehyde binds to and results in decreased activity of PPARG protein CTD PMID:27633901 palmitoyl-CoA multiple interactions ISO RGD:69168 6480464 Palmitoyl Coenzyme A binds to and results in increased activity of PPARG protein CTD PMID:11139385 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PPARG mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:69168 6480464 Acetaminophen results in increased expression of PPARG mRNA CTD PMID:29067470 paracetamol decreases expression ISO RGD:69168 6480464 Acetaminophen results in decreased expression of PPARG mRNA CTD PMID:26690555 paracetamol affects expression ISO RGD:3371 6480464 Acetaminophen affects the expression of PPARG mRNA CTD PMID:16701773 paraquat decreases response to substance EXP 6480464 PPARG gene polymorphism results in decreased susceptibility to Paraquat CTD PMID:18083318 paraquat decreases expression ISO RGD:3371 6480464 Paraquat results in decreased expression of PPARG mRNA, Paraquat results in decreased expression of PPARG protein CTD PMID:30797787 paraquat multiple interactions ISO RGD:3371 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG mRNA]] more ... CTD PMID:30797787 paraquat increases response to substance EXP 6480464 PPARG protein results in increased susceptibility to Paraquat CTD PMID:18083318 parathion-methyl multiple interactions ISO RGD:69168 6480464 Methyl Parathion binds to and results in increased activity of PPARG protein CTD PMID:33049310 parathion-methyl multiple interactions EXP 6480464 Methyl Parathion binds to and results in increased activity of PPARG protein CTD PMID:33049310 paricalcitol multiple interactions ISO RGD:69168 6480464 [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein CTD PMID:17715259 PCB138 multiple interactions EXP 6480464 2 more ... CTD PMID:29704545 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:29704545 PD 0325901 multiple interactions EXP 6480464 mirdametinib inhibits the reaction [Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein] CTD PMID:26670611 penconazole increases expression EXP 6480464 penconazole results in increased expression of PPARG mRNA CTD PMID:31733957 pendimethalin multiple interactions ISO RGD:69168 6480464 pendimethalin binds to and results in increased activity of PPARG protein CTD PMID:33049310 pentachloronitrobenzene increases activity ISO RGD:69168 6480464 quintozene results in increased activity of PPARG protein CTD PMID:20143881 perflubutane affects binding ISO RGD:69168 6480464 perfluorobutane binds to PPARG protein CTD PMID:24998974 perfluorobutanesulfonic acid increases expression EXP 6480464 perfluorobutanesulfonic acid results in increased expression of PPARG mRNA, perfluorobutanesulfonic acid results in increased expression of PPARG protein CTD PMID:30031040 perfluorobutanesulfonic acid affects binding ISO RGD:69168 6480464 perfluorobutanesulfonic acid binds to PPARG protein CTD PMID:35752307 perfluorobutanesulfonic acid affects binding ISO RGD:3371 6480464 perfluorobutanesulfonic acid binds to PPARG protein CTD PMID:35752307 perfluorobutyric acid increases activity ISO RGD:69168 6480464 perfluorobutyric acid results in increased activity of PPARG protein CTD PMID:24998974 perfluorodecanoic acid increases activity ISO RGD:69168 6480464 perfluorodecanoic acid results in increased activity of PPARG protein CTD PMID:23391484 , PMID:24998974 perfluorodecanoic acid increases expression ISO RGD:69168 6480464 perfluorodecanoic acid results in increased expression of PPARG mRNA CTD PMID:35337807 perfluorododecanoic acid increases activity ISO RGD:69168 6480464 perfluorododecanoic acid results in increased activity of PPARG protein CTD PMID:23391484 , PMID:24998974 perfluorododecanoic acid increases expression ISO RGD:69168 6480464 perfluorododecanoic acid results in increased expression of PPARG mRNA CTD PMID:35337807 perfluoroheptanoic acid increases expression ISO RGD:69168 6480464 perfluoro-n-heptanoic acid results in increased expression of PPARG mRNA CTD PMID:35337807 perfluorohexanesulfonic acid affects binding ISO RGD:69168 6480464 perfluorohexanesulfonic acid binds to PPARG protein CTD PMID:24998974 , PMID:35752307 perfluorohexanesulfonic acid increases expression ISO RGD:69168 6480464 perfluorohexanesulfonic acid results in increased expression of PPARG mRNA CTD PMID:35337807 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of PPARG mRNA CTD PMID:28049043 perfluorohexanoic acid increases activity ISO RGD:69168 6480464 perfluorohexanoic acid results in increased activity of PPARG protein CTD PMID:23391484 perfluorohexanoic acid affects binding ISO RGD:69168 6480464 perfluorohexanoic acid binds to PPARG protein CTD PMID:35752307 perfluorohexanoic acid affects binding ISO RGD:3371 6480464 perfluorohexanoic acid binds to PPARG protein CTD PMID:35752307 perfluorononanoic acid increases expression ISO RGD:3371 6480464 perfluoro-n-nonanoic acid results in increased expression of PPARG mRNA CTD PMID:19196829 , PMID:19878704 perfluorononanoic acid increases expression ISO RGD:69168 6480464 perfluoro-n-nonanoic acid results in increased expression of PPARG mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid increases activity ISO RGD:69168 6480464 perfluorooctane sulfonic acid results in increased activity of PPARG protein CTD PMID:24998974 perfluorooctane-1-sulfonic acid affects binding ISO RGD:69168 6480464 perfluorooctane sulfonic acid binds to PPARG protein CTD PMID:35752307 perfluorooctane-1-sulfonic acid affects binding ISO RGD:3371 6480464 perfluorooctane sulfonic acid binds to PPARG protein CTD PMID:35752307 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:69168 6480464 perfluorooctane sulfonic acid results in decreased expression of PPARG mRNA CTD PMID:32790152 perfluorooctane-1-sulfonic acid affects expression ISO RGD:69168 6480464 perfluorooctane sulfonic acid affects the expression of PPARG mRNA CTD PMID:30738844 perfluorooctane-1-sulfonic acid decreases acetylation ISO RGD:3371 6480464 perfluorooctane sulfonic acid results in decreased acetylation of PPARG protein CTD PMID:28973641 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:69168 6480464 perfluorooctane sulfonic acid binds to and results in increased activity of PPARG protein CTD PMID:33049310 perfluorooctane-1-sulfonic acid increases expression ISO RGD:69168 6480464 perfluorooctane sulfonic acid results in increased expression of PPARG mRNA CTD PMID:22269386 more ... perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of PPARG mRNA CTD PMID:23500012 , PMID:26548598 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of PPARG mRNA, perfluorooctane sulfonic acid binds to and results in increased activity of PPARG protein CTD PMID:32979393 , PMID:33049310 perfluorooctane-1-sulfonic acid increases expression ISO RGD:3371 6480464 perfluorooctane sulfonic acid results in increased expression of PPARG mRNA CTD PMID:23500012 perfluorooctanoic acid multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to perfluorooctanoic acid, perfluorooctanoic acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 more ... perfluorooctanoic acid affects binding ISO RGD:3371 6480464 perfluorooctanoic acid binds to PPARG protein CTD PMID:35752307 perfluorooctanoic acid decreases expression ISO RGD:69168 6480464 perfluorooctanoic acid results in decreased expression of PPARG mRNA CTD PMID:32790152 perfluorooctanoic acid increases expression ISO RGD:69168 6480464 perfluorooctanoic acid results in increased expression of PPARG mRNA CTD PMID:25868421 more ... perfluorooctanoic acid increases activity ISO RGD:69168 6480464 perfluorooctanoic acid results in increased activity of PPARG protein CTD PMID:23391484 , PMID:24998974 perfluorooctanoic acid affects binding ISO RGD:69168 6480464 perfluorooctanoic acid binds to PPARG protein CTD PMID:24998974 , PMID:35752307 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of PPARG mRNA CTD PMID:22154759 perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of PPARG mRNA CTD PMID:22154759 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PPARG mRNA, perfluorooctanoic acid results in increased expression of PPARG protein CTD PMID:18281256 more ... perfluorooctanoic acid multiple interactions ISO RGD:3371 6480464 perfluorooctanoic acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 perfluorooctanoic acid multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mRNA] more ... CTD PMID:16731579 more ... perfluoroundecanoic acid multiple interactions ISO RGD:69168 6480464 perfluoroundecanoic acid binds to and affects the folding of PPARG protein CTD PMID:24998974 perfluoroundecanoic acid increases expression ISO RGD:69168 6480464 perfluoroundecanoic acid results in increased expression of PPARG mRNA CTD PMID:35337807 perindopril multiple interactions ISO RGD:3371 6480464 Perindopril inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA], Perindopril inhibits the reaction [Methotrexate results in decreased expression of PPARG protein] CTD PMID:34737150 perindopril increases expression ISO RGD:3371 6480464 Perindopril results in increased expression of PPARG mRNA, Perindopril results in increased expression of PPARG protein CTD PMID:34737150 permethrin multiple interactions ISO RGD:69168 6480464 Permethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA more ... CTD PMID:29751049 , PMID:33049310 permethrin increases expression EXP 6480464 Permethrin results in increased expression of PPARG mRNA, Permethrin results in increased expression of PPARG protein CTD PMID:24911977 phenethyl caffeate decreases expression EXP 6480464 caffeic acid phenethyl ester results in decreased expression of PPARG mRNA CTD PMID:21467634 phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PPARG mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:3371 6480464 Phenobarbital results in increased expression of PPARG mRNA CTD PMID:24090815 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of PPARG mRNA CTD PMID:23091169 phenobarbital affects expression ISO RGD:69168 6480464 Phenobarbital affects the expression of PPARG mRNA CTD PMID:19159669 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of PPARG mRNA CTD PMID:19482888 phenol increases expression ISO RGD:69168 6480464 Phenol results in increased expression of PPARG mRNA CTD PMID:17547211 Phenylamil multiple interactions EXP 6480464 [phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA more ... CTD PMID:20519739 Phenylamil increases expression EXP 6480464 phenylamil results in increased expression of PPARG mRNA CTD PMID:20519739 Phenylamil affects response to substance EXP 6480464 PPARG protein affects the susceptibility to phenylamil CTD PMID:20519739 phloretin multiple interactions EXP 6480464 2 more ... CTD PMID:32408695 phorbol 13-acetate 12-myristate increases activity ISO RGD:69168 6480464 Tetradecanoylphorbol Acetate results in increased activity of PPARG protein CTD PMID:15707588 phorbol 13-acetate 12-myristate increases expression ISO RGD:69168 6480464 Tetradecanoylphorbol Acetate results in increased expression of PPARG mRNA, Tetradecanoylphorbol Acetate results in increased expression of PPARG protein CTD PMID:12044893 , PMID:16945329 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:69168 6480464 [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] more ... CTD PMID:16945329 , PMID:21511917 phosalone multiple interactions EXP 6480464 phosalone binds to and results in increased activity of PPARG protein CTD PMID:33049310 phosalone multiple interactions ISO RGD:69168 6480464 phosalone binds to and results in increased activity of PPARG protein CTD PMID:33049310 phosphatidylcholine increases expression EXP 6480464 Phosphatidylcholines results in increased expression of PPARG mRNA CTD PMID:23911798 phosphorus atom multiple interactions ISO RGD:69168 6480464 [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:69168 6480464 [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein CTD PMID:17715259 phoxim multiple interactions EXP 6480464 phoxim binds to and results in increased activity of PPARG protein CTD PMID:33049310 phoxim multiple interactions ISO RGD:69168 6480464 phoxim binds to and results in increased activity of PPARG protein CTD PMID:33049310 phthalic acid affects binding ISO RGD:69168 6480464 phthalic acid binds to PPARG protein CTD PMID:23843199 phytanic acid affects binding ISO RGD:69168 6480464 Phytanic Acid binds to PPARG protein CTD PMID:23843199 picoxystrobin multiple interactions ISO RGD:69168 6480464 picoxystrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 pioglitazone affects expression ISO RGD:3371 6480464 pioglitazone affects the expression of PPARG mRNA, pioglitazone affects the expression of PPARG protein CTD PMID:28744220 pioglitazone affects binding ISO RGD:69168 6480464 Pioglitazone binds to PPARG protein CTD PMID:11779144 more ... pioglitazone increases activity ISO RGD:69168 6480464 Pioglitazone results in increased activity of PPARG protein CTD PMID:15273253 more ... pioglitazone increases expression EXP 6480464 pioglitazone results in increased expression of PPARG mRNA CTD PMID:11991651 more ... pioglitazone increases expression ISO RGD:69168 6480464 Pioglitazone results in increased expression of PPARG mRNA more ... CTD PMID:11172467 more ... pioglitazone increases activity ISO RGD:3371 6480464 pioglitazone results in increased activity of PPARG protein CTD PMID:19439812 pioglitazone affects response to substance EXP 6480464 PPARG protein affects the susceptibility to pioglitazone CTD PMID:16007095 pioglitazone multiple interactions ISO RGD:3371 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone affects the expression of PPARG mRNA] more ... CTD PMID:12055599 more ... pioglitazone affects expression EXP 6480464 pioglitazone affects the expression of PPARG, pioglitazone affects the expression of PPARG mRNA CTD PMID:19048458 , PMID:21962020 pioglitazone multiple interactions EXP 6480464 [ANGPT2 protein binds to and results in increased activity of AGTR2 protein] promotes the reaction [pioglitazone binds to and results in increased activity of PPARG protein] more ... CTD PMID:11991651 more ... pioglitazone multiple interactions ISO RGD:69168 6480464 [Dexamethasone co-treated with INS protein co-treated with Pioglitazone] results in increased expression of PPARG protein more ... CTD PMID:11779144 more ... pirinixic acid multiple interactions ISO RGD:69168 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA] more ... CTD PMID:11840453 more ... pirinixic acid affects binding ISO RGD:69168 6480464 pirinixic acid binds to PPARG protein CTD PMID:35752307 pirinixic acid affects binding ISO RGD:3371 6480464 pirinixic acid binds to PPARG protein CTD PMID:35752307 pirinixic acid increases activity ISO RGD:69168 6480464 pirinixic acid results in increased activity of PPARG protein CTD PMID:16386710 , PMID:26135921 pirinixic acid increases expression ISO RGD:3371 6480464 pirinixic acid results in increased expression of PPARG mRNA CTD PMID:22539621 pirinixic acid increases activity EXP 6480464 pirinixic acid results in increased activity of PPARG protein CTD PMID:12401884 , PMID:9703482 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid results in increased activity of PPARG protein] which results in increased expression of NFKBIA mRNA more ... CTD PMID:19438714 , PMID:8700121 pirinixic acid increases expression ISO RGD:69168 6480464 pirinixic acid results in increased expression of PPARG mRNA CTD PMID:11840453 platycodin D decreases expression EXP 6480464 platycodin D results in decreased expression of PPARG mRNA, platycodin D results in decreased expression of PPARG protein CTD PMID:20024897 more ... platycodin D decreases expression ISO RGD:69168 6480464 platycodin D results in decreased expression of PPARG protein CTD PMID:30599906 platycodin D decreases activity EXP 6480464 platycodin D results in decreased activity of PPARG protein CTD PMID:20024897 platycodin D multiple interactions EXP 6480464 CTNNB1 affects the reaction [platycodin D results in increased expression of PPARG mRNA] more ... CTD PMID:20024897 , PMID:21798269 Pomiferin decreases expression ISO RGD:69168 6480464 pomiferin results in decreased expression of PPARG mRNA CTD PMID:20706672 potassium chromate multiple interactions EXP 6480464 potassium chromate(VI) inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein] CTD PMID:24576443 prallethrin increases expression ISO RGD:69168 6480464 d, d-T80-prallethrin results in increased expression of PPARG mRNA CTD PMID:32473317 prallethrin multiple interactions EXP 6480464 d, d-T80-prallethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 prallethrin multiple interactions ISO RGD:69168 6480464 d, d-T80-prallethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 Pranoprofen increases activity ISO RGD:69168 6480464 pyranoprofen results in increased activity of PPARG protein CTD PMID:12065695 pravastatin multiple interactions ISO RGD:69168 6480464 Pravastatin inhibits the reaction [[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol] CTD PMID:12044893 prochloraz decreases expression ISO RGD:69168 6480464 prochloraz results in decreased expression of PPARG mRNA CTD PMID:30879083 prochloraz multiple interactions ISO RGD:69168 6480464 prochloraz binds to and results in increased activity of PPARG protein CTD PMID:33049310 prochloraz multiple interactions EXP 6480464 prochloraz binds to and results in increased activity of PPARG protein CTD PMID:33049310 procymidone multiple interactions EXP 6480464 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PPARG mRNA, procymidone binds to and results in increased activity of PPARG protein CTD PMID:33049310 , PMID:33246813 procymidone decreases expression EXP 6480464 procymidone results in decreased expression of PPARG mRNA CTD PMID:33246813 progesterone increases expression ISO RGD:3371 6480464 Progesterone results in increased expression of PPARG mRNA CTD PMID:16954335 propamocarb decreases expression EXP 6480464 propamocarb results in decreased expression of PPARG mRNA CTD PMID:29137890 propanil multiple interactions EXP 6480464 Propanil binds to and results in increased activity of PPARG protein CTD PMID:33049310 propanil multiple interactions ISO RGD:69168 6480464 Propanil binds to and results in increased activity of PPARG protein CTD PMID:33049310 propargite multiple interactions ISO RGD:69168 6480464 Omite binds to and results in increased activity of PPARG protein CTD PMID:33049310 propargite multiple interactions EXP 6480464 Omite binds to and results in increased activity of PPARG protein CTD PMID:33049310 propiconazole multiple interactions EXP 6480464 propiconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 propiconazole multiple interactions ISO RGD:69168 6480464 propiconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 propylparaben increases expression EXP 6480464 propylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 propylparaben multiple interactions EXP 6480464 PPARG protein promotes the reaction [propylparaben binds to and results in increased activity of PPARG protein], propylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 , PMID:33049310 propylparaben multiple interactions ISO RGD:69168 6480464 propylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 , PMID:33049310 propyzamide multiple interactions EXP 6480464 pronamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 propyzamide multiple interactions ISO RGD:69168 6480464 pronamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 prostaglandin D2 multiple interactions ISO RGD:69168 6480464 Prostaglandin D2 affects the localization of and results in increased expression of PPARG protein CTD PMID:23943857 prostaglandin D2 affects localization ISO RGD:69168 6480464 Prostaglandin D2 affects the localization of PPARG protein CTD PMID:23220503 prostaglandin F2alpha multiple interactions EXP 6480464 [Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG mRNA, [Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG protein CTD PMID:21236357 prostaglandin J2 multiple interactions ISO RGD:69168 6480464 9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein more ... CTD PMID:11343236 more ... prostaglandin J2 increases expression ISO RGD:69168 6480464 9-deoxy-delta-9-prostaglandin D2 results in increased expression of PPARG mRNA CTD PMID:12595494 , PMID:14512786 prostaglandin J2 increases activity ISO RGD:69168 6480464 9-deoxy-delta-9-prostaglandin D2 results in increased activity of PPARG protein CTD PMID:17030193 prostaglandin J2 multiple interactions ISO RGD:3371 6480464 9-deoxy-delta-9-prostaglandin D2 promotes the reaction [PPARG protein alternative form results in decreased activity of SLC2A4 promoter], [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter] CTD PMID:12777391 , PMID:15150131 protein kinase inhibitor multiple interactions EXP 6480464 mirdametinib inhibits the reaction [Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein], Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein CTD PMID:26670611 psoralen multiple interactions ISO RGD:3371 6480464 Ficusin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA] CTD PMID:27350165 puerarin multiple interactions ISO RGD:3371 6480464 puerarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein] CTD PMID:23500774 puerarin decreases expression ISO RGD:69168 6480464 puerarin results in decreased expression of PPARG mRNA CTD PMID:20706672 pyocyanine decreases expression EXP 6480464 Pyocyanine results in decreased expression of PPARG mRNA CTD PMID:31078726 pyrene multiple interactions EXP 6480464 pyrene binds to and results in increased activity of PPARG protein CTD PMID:33049310 pyrene multiple interactions ISO RGD:69168 6480464 pyrene binds to and results in increased activity of PPARG protein CTD PMID:33049310 pyridaben multiple interactions EXP 6480464 pyridaben binds to and results in increased activity of PPARG protein CTD PMID:33049310 pyridaben multiple interactions ISO RGD:69168 6480464 pyridaben binds to and results in increased activity of PPARG protein, pyridaben inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 , PMID:33049310 Pyridostigmine bromide multiple interactions EXP 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA, Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 quercetin increases expression ISO RGD:69168 6480464 Quercetin results in increased expression of PPARG mRNA, Quercetin results in increased expression of PPARG protein CTD PMID:25765892 quercetin multiple interactions ISO RGD:3371 6480464 [Dietary Fats co-treated with Quercetin] affects the expression of PPARG mRNA more ... CTD PMID:20580672 , PMID:24039778 quercetin multiple interactions EXP 6480464 Quercetin binds to and results in increased activity of PPARG protein more ... CTD PMID:18262572 more ... quercetin multiple interactions ISO RGD:69168 6480464 Quercetin inhibits the reaction [ciglitazone results in increased activity of PPARG protein], Quercetin promotes the reaction [rosiglitazone results in increased expression of PPARG protein] CTD PMID:18393431 , PMID:25765892 quinoline multiple interactions ISO RGD:69168 6480464 quinoline analog binds to and affects the activity of PPARG protein CTD PMID:17610302 quinolinic acid decreases expression ISO RGD:3371 6480464 Quinolinic Acid results in decreased expression of PPARG mRNA CTD PMID:30130594 quinolinic acid multiple interactions ISO RGD:3371 6480464 [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA] more ... CTD PMID:30130594 quinoxyfen increases expression ISO RGD:69168 6480464 quinoxyfen results in increased expression of PPARG mRNA CTD PMID:32473317 quizalofop-ethyl increases activity ISO RGD:69168 6480464 quizalofop-ethyl results in increased activity of PPARG protein CTD PMID:31086981 reactive oxygen species multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:16945329 more ... reactive oxygen species multiple interactions EXP 6480464 [Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein, Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein] CTD PMID:22046279 rebaudioside A multiple interactions EXP 6480464 rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 resmethrin increases activity ISO RGD:69168 6480464 resmethrin results in increased activity of PPARG protein CTD PMID:20143881 resveratrol multiple interactions EXP 6480464 [Resveratrol co-treated with Dietary Fats] results in decreased expression of PPARG mRNA more ... CTD PMID:18555852 more ... resveratrol multiple interactions ISO RGD:3371 6480464 Resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] more ... CTD PMID:18793633 more ... resveratrol affects activity EXP 6480464 resveratrol affects the activity of PPARG protein CTD PMID:23525482 resveratrol affects response to substance EXP 6480464 PPARG protein affects the susceptibility to resveratrol CTD PMID:23525482 resveratrol decreases expression ISO RGD:69168 6480464 resveratrol results in decreased expression of PPARG mRNA, resveratrol results in decreased expression of PPARG protein CTD PMID:20706672 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of PPARG protein CTD PMID:24036142 resveratrol decreases expression ISO RGD:3371 6480464 resveratrol results in decreased expression of PPARG mRNA CTD PMID:23848300 resveratrol increases expression ISO RGD:69168 6480464 resveratrol analog results in increased expression of PPARG mRNA more ... CTD PMID:20372816 more ... resveratrol multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Resveratrol results in increased expression of PPARG mRNA] more ... CTD PMID:18776171 more ... resveratrol increases activity ISO RGD:69168 6480464 resveratrol results in increased activity of PPARG protein CTD PMID:16849586 more ... resveratrol decreases expression EXP 6480464 resveratrol analog results in decreased expression of PPARG mRNA more ... CTD PMID:16813520 more ... retinyl acetate multiple interactions EXP 6480464 [retinol acetate co-treated with 2 more ... CTD PMID:31449830 riddelliine decreases expression ISO RGD:3371 6480464 riddelliine results in decreased expression of PPARG mRNA CTD PMID:18047727 rifampicin increases expression EXP 6480464 Rifampin results in increased expression of PPARG mRNA CTD PMID:27806127 rifampicin multiple interactions EXP 6480464 [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of PPARG mRNA more ... CTD PMID:27806127 , PMID:33412187 rifaximin multiple interactions ISO RGD:69168 6480464 [NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of PPARG mRNA CTD PMID:22790967 rimonabant affects expression EXP 6480464 Rimonabant affects the expression of PPARG mRNA CTD PMID:20110567 risperidone increases expression EXP 6480464 Risperidone results in increased expression of PPARG mRNA, Risperidone results in increased expression of PPARG protein CTD PMID:20564506 risperidone multiple interactions EXP 6480464 Berberine inhibits the reaction [Risperidone results in increased expression of PPARG mRNA], Berberine inhibits the reaction [Risperidone results in increased expression of PPARG protein] CTD PMID:20564506 ritonavir multiple interactions EXP 6480464 Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein] CTD PMID:11101056 ritonavir increases expression ISO RGD:69168 6480464 Ritonavir results in increased expression of PPARG mRNA CTD PMID:17879945 Ro 41-5253 multiple interactions EXP 6480464 [Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein, Ro 41-5253 results in increased activity of and results in decreased expression of PPARG protein CTD PMID:17290005 Ro 41-5253 multiple interactions ISO RGD:69168 6480464 [Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein more ... CTD PMID:17290005 Rosavin decreases expression ISO RGD:69168 6480464 rosavin results in decreased expression of PPARG mRNA CTD PMID:20706672 rosmarinic acid multiple interactions ISO RGD:3371 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [rosmarinic acid affects the expression of PPARG mRNA] more ... CTD PMID:28744220 rosmarinic acid affects expression ISO RGD:3371 6480464 rosmarinic acid affects the expression of PPARG mRNA, rosmarinic acid affects the expression of PPARG protein CTD PMID:28744220 rotenone decreases expression ISO RGD:3371 6480464 Rotenone results in decreased expression of PPARG mRNA, Rotenone results in decreased expression of PPARG protein CTD PMID:19693701 rotenone multiple interactions ISO RGD:69168 6480464 [Rosiglitazone co-treated with Rotenone] results in increased expression of PPARG protein, Rotenone inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:24374061 , PMID:30818834 rottlerin multiple interactions ISO RGD:69168 6480464 rottlerin inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein] CTD PMID:17030193 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 PPARG mRNA promotes the reaction [Tamoxifen inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]], S-ethyl glutathione inhibits the reaction [Buthionine Sulfoximine results in increased expression of PPARG mRNA] CTD PMID:21520053 , PMID:27358406 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression EXP 6480464 Buthionine Sulfoximine results in increased expression of PPARG mRNA CTD PMID:21520053 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:3371 6480464 Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA] more ... CTD PMID:17602960 salicylic acid multiple interactions ISO RGD:3371 6480464 Salicylic Acid inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] CTD PMID:25108154 Salmeterol xinafoate multiple interactions ISO RGD:69168 6480464 Salmeterol Xinafoate promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]] CTD PMID:15531761 SB 203580 multiple interactions EXP 6480464 [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form] CTD PMID:14984747 SB 203580 multiple interactions ISO RGD:3371 6480464 SB 203580 inhibits the reaction [Ethanol results in decreased expression of PPARG protein] CTD PMID:24412557 SB 203580 increases expression ISO RGD:3371 6480464 SB 203580 results in increased expression of PPARG mRNA, SB 203580 results in increased expression of PPARG protein CTD PMID:24412557 SB 203580 decreases expression EXP 6480464 SB 203580 results in decreased expression of PPARG mRNA, SB 203580 results in decreased expression of PPARG protein CTD PMID:23603106 SB 431542 multiple interactions ISO RGD:69168 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPARG mRNA CTD PMID:27188386 SB-239063 multiple interactions ISO RGD:3371 6480464 SB 239063 inhibits the reaction [25-hydroxyprotopanaxadiol results in increased phosphorylation of PPARG protein] CTD PMID:33676887 selenic acid increases expression EXP 6480464 Selenic Acid results in increased expression of PPARG mRNA CTD PMID:16443359 selenium atom multiple interactions EXP 6480464 PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide more ... CTD PMID:17439952 serotonin increases localization ISO RGD:69168 6480464 Serotonin results in increased localization of PPARG protein CTD PMID:25766885 serotonin multiple interactions ISO RGD:69168 6480464 [Serotonin results in increased localization of and results in increased activity of PPARG protein] which results in increased expression of AQP3 mRNA, Fluoxetine inhibits the reaction [Serotonin results in increased localization of PPARG protein] CTD PMID:25766885 sildenafil citrate multiple interactions EXP 6480464 8-(4-chlorophenylthio)guanosine 3', 5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of PPARG protein] CTD PMID:20471953 sildenafil citrate increases expression EXP 6480464 Sildenafil Citrate results in increased expression of PPARG mRNA, Sildenafil Citrate results in increased expression of PPARG protein CTD PMID:20471953 silibinin multiple interactions EXP 6480464 Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein] CTD PMID:25559859 silibinin increases expression ISO RGD:69168 6480464 Silybin results in increased expression of PPARG protein CTD PMID:27746612 silicon dioxide increases expression ISO RGD:69168 6480464 Silicon Dioxide analog results in increased expression of PPARG mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:3371 6480464 Silicon Dioxide results in increased expression of PPARG mRNA CTD PMID:32721576 simvastatin multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 mRNA], [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 protein] CTD PMID:15781755 simvastatin decreases expression ISO RGD:3371 6480464 Simvastatin results in decreased expression of PPARG CTD PMID:19216230 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol more ... CTD PMID:20835264 sirolimus affects expression ISO RGD:69168 6480464 Sirolimus affects the expression of PPARG protein CTD PMID:17016853 sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of PPARG mRNA CTD PMID:15358118 sirolimus multiple interactions ISO RGD:69168 6480464 [Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein, [Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein CTD PMID:17016853 sodium arsenate decreases expression EXP 6480464 sodium arsenate analog results in decreased expression of PPARG mRNA CTD PMID:23221991 sodium arsenate decreases expression ISO RGD:69168 6480464 sodium arsenate analog results in decreased expression of PPARG mRNA CTD PMID:23221991 sodium arsenite decreases expression ISO RGD:69168 6480464 sodium arsenite results in decreased expression of PPARG mRNA CTD PMID:23221991 sodium arsenite increases expression ISO RGD:3371 6480464 sodium arsenite results in increased expression of PPARG protein CTD PMID:28283887 sodium arsenite decreases expression ISO RGD:3371 6480464 sodium arsenite results in decreased expression of PPARG protein CTD PMID:30551535 sodium arsenite multiple interactions ISO RGD:3371 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 more ... sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PPARG mRNA, sodium arsenite results in increased expression of PPARG protein CTD PMID:25367288 more ... sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of PPARG mRNA, sodium arsenite results in decreased expression of PPARG protein CTD PMID:21396911 more ... sodium arsenite multiple interactions EXP 6480464 [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of PPARG mRNA more ... CTD PMID:11812925 more ... sodium atom affects abundance EXP 6480464 PPARG protein affects the abundance of Sodium CTD PMID:16007095 Sodium oleate multiple interactions ISO RGD:69168 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA CTD PMID:32613381 Sorbitan monooleate multiple interactions ISO RGD:69168 6480464 sorbitan monooleate binds to and results in increased activity of PPARG protein CTD PMID:27131391 splitomicin multiple interactions EXP 6480464 splitomicin promotes the reaction [resveratrol results in decreased expression of PPARG mRNA], splitomicin promotes the reaction [resveratrol results in decreased expression of PPARG protein] CTD PMID:23525482 stavudine decreases expression ISO RGD:69168 6480464 Stavudine results in decreased expression of PPARG mRNA CTD PMID:14518702 stavudine decreases expression EXP 6480464 Stavudine results in decreased expression of PPARG mRNA, Stavudine results in decreased expression of PPARG protein CTD PMID:15722030 , PMID:17926646 stearoyl-CoA multiple interactions ISO RGD:69168 6480464 stearoyl-coenzyme A binds to and results in increased activity of PPARG protein CTD PMID:11139385 steviol multiple interactions EXP 6480464 steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 stevioside multiple interactions EXP 6480464 stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 stilben-4-ol decreases expression EXP 6480464 4-hydroxystilbene results in decreased expression of PPARG mRNA CTD PMID:23748787 streptozocin decreases expression ISO RGD:3371 6480464 Streptozocin results in decreased expression of PPARG more ... CTD PMID:12967931 more ... streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of PPARG mRNA CTD PMID:23319174 streptozocin increases expression ISO RGD:3371 6480464 Streptozocin results in increased expression of PPARG mRNA, Streptozocin results in increased expression of PPARG protein CTD PMID:20219977 , PMID:21450970 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of PPARG mRNA, Streptozocin results in decreased expression of PPARG protein CTD PMID:21381899 , PMID:30642005 streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of PPARG mRNA more ... CTD PMID:21381899 more ... streptozocin multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:12967931 more ... succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PPARG mRNA CTD PMID:26378955 sucrose multiple interactions EXP 6480464 [lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA, Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA] CTD PMID:24440342 sulfasalazine increases expression ISO RGD:3371 6480464 Sulfasalazine results in increased expression of PPARG mRNA CTD PMID:19365232 sulfasalazine multiple interactions ISO RGD:3371 6480464 Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA], Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein] CTD PMID:26165751 sulfasalazine increases expression EXP 6480464 Sulfasalazine results in increased expression of PPARG mRNA CTD PMID:31830553 sulfluramid affects binding ISO RGD:3371 6480464 sulfluramid binds to PPARG protein CTD PMID:35752307 sulfluramid affects binding ISO RGD:69168 6480464 sulfluramid binds to PPARG protein CTD PMID:35752307 sulfluramid increases expression ISO RGD:69168 6480464 sulfluramid results in increased expression of PPARG mRNA CTD PMID:35337807 sulforaphane increases expression ISO RGD:69168 6480464 sulforaphane results in increased expression of PPARG mRNA CTD PMID:26833863 sulfur dioxide multiple interactions EXP 6480464 glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein] more ... CTD PMID:26209559 sulfur dioxide decreases expression EXP 6480464 Sulfur Dioxide results in decreased expression of PPARG protein CTD PMID:26209559 sulindac sulfide multiple interactions ISO RGD:69168 6480464 [sulindac sulfide results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein more ... CTD PMID:10866999 more ... sulindac sulfide increases expression ISO RGD:69168 6480464 sulindac sulfide results in increased expression of PPARG mRNA CTD PMID:11948457 sulindac sulfide increases activity ISO RGD:69168 6480464 sulindac sulfide results in increased activity of PPARG protein CTD PMID:10866999 sulindac sulfide affects binding ISO RGD:69168 6480464 sulindac sulfide analog binds to PPARG protein CTD PMID:18665581 sulindac sulfone multiple interactions ISO RGD:69168 6480464 [sulindac sulfone results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to SAT1 enhancer], PPARG protein promotes the reaction [sulindac sulfone results in increased expression of SAT1 mRNA] CTD PMID:14506281 sulindac sulfone increases expression ISO RGD:69168 6480464 sulindac sulfone results in increased expression of PPARG mRNA CTD PMID:11948457 sunitinib decreases expression ISO RGD:69168 6480464 Sunitinib results in decreased expression of PPARG mRNA CTD PMID:31533062 T-2 toxin increases expression ISO RGD:3371 6480464 T-2 Toxin results in increased expression of PPARG mRNA CTD PMID:26141394 tacrolimus hydrate multiple interactions ISO RGD:69168 6480464 [Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein CTD PMID:17016853 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of PPARG mRNA CTD PMID:25123088 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of PPARG protein CTD PMID:27358406 tamoxifen multiple interactions EXP 6480464 PPARG mRNA promotes the reaction [Tamoxifen inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]] more ... CTD PMID:27358406 , PMID:33049310 tamoxifen multiple interactions ISO RGD:69168 6480464 Tamoxifen inhibits the reaction [PPARG protein binds to CD36 promoter] more ... CTD PMID:27358406 Tanshinone I decreases expression EXP 6480464 tanshinone results in decreased expression of PPARG mRNA CTD PMID:20854809 taurine multiple interactions ISO RGD:3371 6480464 Taurine inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein] CTD PMID:30551535 taurine multiple interactions ISO RGD:69168 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein] CTD PMID:30362509 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein] CTD PMID:30362509 tebuconazole multiple interactions ISO RGD:69168 6480464 tebuconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 tebuconazole multiple interactions EXP 6480464 tebuconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 tebufenpyrad increases activity ISO RGD:69168 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased activity of PPARG protein CTD PMID:20143881 telmisartan multiple interactions ISO RGD:69168 6480464 PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]] more ... CTD PMID:18158351 , PMID:22124178 telmisartan multiple interactions ISO RGD:3371 6480464 telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA], telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] CTD PMID:20888384 , PMID:24831514 telmisartan increases expression EXP 6480464 telmisartan results in increased expression of PPARG protein CTD PMID:20176998 telmisartan multiple interactions EXP 6480464 telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] CTD PMID:21381899 telmisartan increases activity ISO RGD:69168 6480464 Telmisartan results in increased activity of PPARG protein CTD PMID:22124178 , PMID:28728110 temozolomide decreases expression ISO RGD:69168 6480464 Temozolomide results in decreased expression of PPARG mRNA CTD PMID:31758290 tenofovir disoproxil fumarate affects expression ISO RGD:69168 6480464 Tenofovir affects the expression of PPARG mRNA CTD PMID:20032539 tert-butyl ethyl ether increases expression ISO RGD:3371 6480464 ethyl tert-butyl ether results in increased expression of PPARG mRNA CTD PMID:24090815 tert-butyl hydroperoxide multiple interactions ISO RGD:69168 6480464 tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter] more ... CTD PMID:20847119 tert-butyl hydroperoxide increases activity ISO RGD:69168 6480464 tert-Butylhydroperoxide results in increased activity of PPARG protein CTD PMID:16417216 Tesaglitazar multiple interactions ISO RGD:69168 6480464 tesaglitazar binds to and results in increased activity of PPARG protein CTD PMID:17610302 Tesaglitazar affects expression ISO RGD:3371 6480464 tesaglitazar affects the expression of PPARG mRNA CTD PMID:21270424 Tesaglitazar increases activity EXP 6480464 tesaglitazar results in increased activity of PPARG protein CTD PMID:12401884 Tesaglitazar increases activity ISO RGD:69168 6480464 tesaglitazar results in increased activity of PPARG protein CTD PMID:12401884 testosterone decreases expression ISO RGD:69168 6480464 Testosterone results in decreased expression of PPARG mRNA CTD PMID:21632903 , PMID:33359661 testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of PPARG mRNA, Testosterone results in decreased expression of PPARG protein CTD PMID:12960001 , PMID:20844152 Testosterone propionate multiple interactions ISO RGD:69168 6480464 Testosterone Propionate binds to and results in decreased activity of PPARG protein CTD PMID:33049310 Tetrachlorobisphenol A increases activity ISO RGD:69168 6480464 tetrachlorodian analog results in increased activity of PPARG protein, tetrachlorodian results in increased activity of PPARG protein CTD PMID:24591153 more ... Tetrachlorobisphenol A affects binding ISO RGD:69168 6480464 tetrachlorodian binds to PPARG protein CTD PMID:25314719 Tetrachlorobisphenol A multiple interactions EXP 6480464 tetrachlorodian binds to and results in increased activity of PPARG protein CTD PMID:33049310 Tetrachlorobisphenol A multiple interactions ISO RGD:69168 6480464 tetrachlorodian binds to and results in increased activity of PPARG protein more ... CTD PMID:21561829 more ... tetrachloromethane multiple interactions ISO RGD:3371 6480464 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA] more ... CTD PMID:12055599 more ... tetrachloromethane increases expression ISO RGD:3371 6480464 Carbon Tetrachloride results in increased expression of PPARG mRNA CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PPARG mRNA, Carbon Tetrachloride results in decreased expression of PPARG protein CTD PMID:28428136 tetrachloromethane multiple interactions EXP 6480464 [Ethanol co-treated with Carbon Tetrachloride co-treated with 4-O-methylhonokiol] results in decreased expression of PPARG mRNA more ... CTD PMID:28428136 , PMID:28689299 tetrachloromethane decreases activity ISO RGD:3371 6480464 Carbon Tetrachloride results in decreased activity of PPARG protein CTD PMID:25858767 tetrachloromethane decreases expression ISO RGD:3371 6480464 Carbon Tetrachloride results in decreased expression of PPARG mRNA, Carbon Tetrachloride results in decreased expression of PPARG protein CTD PMID:12055599 more ... tetrachloromethane affects expression ISO RGD:3371 6480464 Carbon Tetrachloride affects the expression of PPARG protein CTD PMID:15959796 tetrachlorvinphos multiple interactions ISO RGD:69168 6480464 Tetrachlorvinphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 tetrachlorvinphos multiple interactions EXP 6480464 Tetrachlorvinphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 tetramethylpyrazine increases expression ISO RGD:3371 6480464 tetramethylpyrazine results in increased expression of PPARG protein CTD PMID:23022513 tetramethylpyrazine increases expression ISO RGD:69168 6480464 tetramethylpyrazine results in increased expression of PPARG mRNA CTD PMID:28034800 tetramethylpyrazine multiple interactions EXP 6480464 tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein] CTD PMID:22200888 theophylline increases expression ISO RGD:69168 6480464 Theophylline results in increased expression of PPARG mRNA, Theophylline results in increased expression of PPARG protein CTD PMID:16569937 thiamine(1+) chloride increases activity ISO RGD:3371 6480464 Thiamine results in increased activity of PPARG protein CTD PMID:31419397 thiamine(1+) chloride multiple interactions ISO RGD:3371 6480464 Thiamine inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:31419397 thiazolidinediones multiple interactions ISO RGD:3371 6480464 [Thiazolidinediones binds to and results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides, Thiazolidinediones binds to and results in increased activity of PPARG protein CTD PMID:19248225 thiazolidinediones multiple interactions ISO RGD:69168 6480464 PPARG protein promotes the reaction [Thiazolidinediones results in increased abundance of Lipids] CTD PMID:20079722 thiazolidinediones increases expression EXP 6480464 Thiazolidinediones results in increased expression of PPARG mRNA CTD PMID:21870829 thioacetamide increases expression ISO RGD:3371 6480464 Thioacetamide results in increased expression of PPARG mRNA CTD PMID:23411599 thymoquinone multiple interactions ISO RGD:69168 6480464 PRKAA1 protein promotes the reaction [thymoquinone results in increased expression of PPARG protein], thymoquinone inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein] CTD PMID:27688165 thymoquinone increases expression ISO RGD:69168 6480464 thymoquinone results in increased expression of PPARG protein CTD PMID:27688165 thyroxine multiple interactions EXP 6480464 Thyroxine inhibits the reaction [Triclosan results in decreased expression of PPARG protein] CTD PMID:28973666 tideglusib multiple interactions ISO RGD:69168 6480464 tideglusib inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein] CTD PMID:30965670 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of PPARG mRNA, titanium dioxide results in decreased expression of PPARG protein CTD PMID:23557971 , PMID:28646487 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARG mRNA CTD PMID:29950665 toluene 2,4-diisocyanate multiple interactions EXP 6480464 pioglitazone promotes the reaction [Toluene 2 more ... CTD PMID:17015710 toluene 2,4-diisocyanate increases localization EXP 6480464 Toluene 2, 4-Diisocyanate results in increased localization of PPARG protein CTD PMID:17015710 tomelukast multiple interactions EXP 6480464 LY 171883 results in increased activity of [PPARG protein co-treated with RXRA protein] CTD PMID:8700121 topotecan affects expression ISO RGD:3371 6480464 Topotecan affects the expression of PPARG mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:3371 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PPARG mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:69168 6480464 torcetrapib results in increased expression of PPARG mRNA CTD PMID:25617244 torcetrapib multiple interactions ISO RGD:69168 6480464 2-acetylphenothiazine inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA], setanaxib inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA] CTD PMID:25617244 trans-caffeic acid increases expression EXP 6480464 caffeic acid results in increased expression of PPARG mRNA CTD PMID:21870829 trans-chalcone increases expression EXP 6480464 Chalcone analog results in increased expression of PPARG mRNA CTD PMID:28528971 trans-cinnamic acid increases expression EXP 6480464 cinnamic acid results in increased expression of PPARG mRNA CTD PMID:21870829 tributyl phosphate affects binding ISO RGD:69168 6480464 tributyl phosphate binds to PPARG protein CTD PMID:25314719 , PMID:30966736 tributyl phosphate increases activity ISO RGD:69168 6480464 tributyl phosphate results in increased activity of PPARG protein CTD PMID:26172262 , PMID:28282128 tributyl phosphate multiple interactions ISO RGD:69168 6480464 tributyl phosphate binds to and results in increased activity of PPARG protein CTD PMID:33049310 tributyl phosphate multiple interactions EXP 6480464 tributyl phosphate binds to and results in increased activity of PPARG protein CTD PMID:33049310 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of PPARG mRNA, tributyltin results in increased expression of PPARG protein CTD PMID:21622945 more ... tributylstannane multiple interactions ISO RGD:3371 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of PPARG protein CTD PMID:31129395 tributylstannane increases expression ISO RGD:69168 6480464 tributyltin results in increased expression of PPARG mRNA CTD PMID:26961604 , PMID:29787037 tributylstannane increases expression ISO RGD:3371 6480464 tributyltin results in increased expression of PPARG protein CTD PMID:25819109 more ... tributylstannane affects binding ISO RGD:69168 6480464 tributyltin binds to PPARG protein CTD PMID:25314719 , PMID:32407875 tributylstannane increases activity EXP 6480464 tributyltin results in increased activity of PPARG protein CTD PMID:25777084 tributylstannane multiple interactions ISO RGD:69168 6480464 T 0070907 inhibits the reaction [tributyltin results in increased expression of PPARG mRNA] more ... CTD PMID:19497422 more ... tributylstannane multiple interactions EXP 6480464 PPARG protein promotes the reaction [tributyltin binds to and results in increased activity of PPARG protein] more ... CTD PMID:22197818 more ... tributylstannane increases activity ISO RGD:69168 6480464 tributyltin results in increased activity of PPARG protein CTD PMID:21622945 more ... Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of PPARG mRNA CTD PMID:18958704 trichloroethene multiple interactions EXP 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of PPARG mRNA] CTD PMID:20709644 trichloroethene increases expression ISO RGD:3371 6480464 Trichloroethylene results in increased expression of PPARG mRNA CTD PMID:33387578 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PPARG mRNA CTD PMID:20709644 triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of PPARG mRNA, Triclosan results in decreased expression of PPARG protein CTD PMID:15707987 , PMID:28973666 triclosan increases expression ISO RGD:69168 6480464 Triclosan results in increased expression of PPARG mRNA CTD PMID:30510588 triclosan affects expression ISO RGD:69168 6480464 Triclosan affects the expression of PPARG mRNA CTD PMID:31714634 triclosan multiple interactions EXP 6480464 [Rosiglitazone results in increased activity of PPARG protein] inhibits the reaction [Triclosan results in decreased phosphorylation of AKT1 protein] more ... CTD PMID:28973666 more ... triclosan multiple interactions ISO RGD:69168 6480464 Triclosan binds to and results in increased activity of PPARG protein CTD PMID:33049310 triclosan increases expression EXP 6480464 Triclosan results in increased expression of PPARG protein CTD PMID:33722737 triclosan affects binding ISO RGD:69168 6480464 Triclosan binds to PPARG protein CTD PMID:25314719 triflumizole increases activity EXP 6480464 triflumizol results in increased activity of PPARG protein CTD PMID:23086663 triflumizole multiple interactions ISO RGD:69168 6480464 triflumizol binds to and results in increased activity of PPARG protein CTD PMID:33049310 triflumizole multiple interactions EXP 6480464 triflumizol binds to and results in increased activity of PPARG protein CTD PMID:33049310 triflumizole increases expression EXP 6480464 triflumizol results in increased expression of PPARG mRNA CTD PMID:23086663 triflumizole increases activity ISO RGD:69168 6480464 triflumizol results in increased activity of PPARG protein CTD PMID:20143881 trifluralin multiple interactions EXP 6480464 Trifluralin binds to and results in increased activity of PPARG protein CTD PMID:33049310 trifluralin multiple interactions ISO RGD:69168 6480464 Trifluralin binds to and results in increased activity of PPARG protein CTD PMID:33049310 triphenyl phosphate multiple interactions EXP 6480464 [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA more ... CTD PMID:29112739 more ... triphenyl phosphate increases activity ISO RGD:69168 6480464 triphenyl phosphate results in increased activity of PPARG protein CTD PMID:26172262 more ... triphenyl phosphate multiple interactions ISO RGD:69168 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of PPARG mRNA more ... CTD PMID:28282128 more ... triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of PPARG mRNA CTD PMID:28163246 triphenyl phosphate affects binding ISO RGD:69168 6480464 triphenyl phosphate binds to PPARG protein, triphenyl phosphate metabolite binds to PPARG protein CTD PMID:25062436 , PMID:25314719 triphenyl phosphate increases expression ISO RGD:69168 6480464 triphenyl phosphate results in increased expression of PPARG mRNA CTD PMID:25062436 , PMID:28934090 triphenylstannane multiple interactions ISO RGD:69168 6480464 triphenyltin binds to and results in increased activity of PPARG protein CTD PMID:24786373 triphenylstannane affects binding ISO RGD:69168 6480464 triphenyltin binds to PPARG protein CTD PMID:25314719 , PMID:27725436 triphenylstannane increases activity EXP 6480464 triphenyltin results in increased activity of PPARG protein CTD PMID:25777084 triphenylstannane decreases expression ISO RGD:3371 6480464 triphenyltin results in decreased expression of PPARG mRNA CTD PMID:32504733 triptonide decreases expression EXP 6480464 triptonide results in decreased expression of PPARG mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects binding ISO RGD:69168 6480464 tris(2-butoxyethyl) phosphate binds to PPARG protein CTD PMID:25314719 tris(2-chloroethyl) phosphate decreases expression ISO RGD:69168 6480464 tris(chloroethyl)phosphate results in decreased expression of PPARG protein CTD PMID:30966736 tris(2-chloroethyl) phosphate increases expression EXP 6480464 tris(chloroethyl)phosphate results in increased expression of PPARG mRNA, tris(chloroethyl)phosphate results in increased expression of PPARG protein CTD PMID:35780845 tris(2-chloroethyl) phosphate multiple interactions EXP 6480464 Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of PPARG mRNA], Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of PPARG protein] CTD PMID:35780845 triticonazole multiple interactions EXP 6480464 triticonazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 troglitazone increases response to substance ISO RGD:69168 6480464 PPARG protein results in increased susceptibility to troglitazone CTD PMID:12824901 troglitazone increases activity ISO RGD:69168 6480464 troglitazone results in increased activity of PPARG protein CTD PMID:15345676 more ... troglitazone multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:10871190 more ... troglitazone affects activity ISO RGD:3371 6480464 troglitazone affects the activity of PPARG protein CTD PMID:25596134 troglitazone decreases methylation EXP 6480464 troglitazone results in decreased methylation of PPARG promoter CTD 
